Focal epilepsy, strict definition

FE_STRICT

partial epilepsy: A seizure caused by a localized disorder.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions not GE	555819
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints FE	10406
6. Filter based on genotype QC (FinnGen only)	9300

Control definitions (FinnGen only)

Control exclude: G6_EPLEPSY
Control conditions: not GE

Extra metadata

First used in FinnGen datafreeze: DF3

NAME	FE_STRICT
CONTROL_EXCLUDE	G6_EPLEPSY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!GE
SEX
INCLUDE	FE
PRE_CONDITIONS
CONDITIONS	!GE
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Focal epilepsy, strict definition based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	83361	38369	44332
Only index persons	69676	32994	36682
Unadjusted period prevalence (%)
Whole population	1.17	1.10	1.24
Only index persons	1.31	1.21	1.40
Median age at first event (years)
Whole population	53.68	53.75	53.47
Only index persons	52.12	52.25	52.00

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9300	4580	4720
Unadjusted period prevalence (%)	1.90	1.63	2.16
Median age at first event (years)	56.38	51.88	60.74

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9577: Matched controls
95733

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

9.9

319.7

373

391

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.6

319.5

2283

10150

C71.20

ICD-10 Finland

Malignant tumor in temporal lobe without histology

98.7

318.1

165

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

5.2

307.7

1650

3718

N05BA09

ATC

clobazam; oral

344.9

307.7

733

G40.10

ICD-10 Finland

Simple partial seizures

13120.9

307.7

1166

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.7

307.7

812

1869

N03AF02

ATC

oxcarbazepine; oral

180.4

307.7

4097

395

N05CD08

ATC

midazolam; nasal, systemic

10.6

307.7

724

732

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

16384.0

307.7

3559

C71.11

ICD-10 Finland

Malignant tumor of frontal lobe grade II glioma

165.7

307.7

163

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

41.9

307.7

417

104

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

3.7

307.7

1693

5311

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

16384.0

307.7

1525

G40

ICD-10 Finland

Epilepsy

1088.7

307.7

978

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

+∞

307.7

1348

L01AX03

ATC

temozolomide; systemic

46.1

307.7

536

123

N03AG01

ATC

valproic acid; systemic, rectal

25.8

307.7

3222

1848

N03AF01

ATC

carbamazepine; oral, rectal

18.2

307.7

2200

1542

183

Kela drug reimbursment

Lamotrigin and topiramate

+∞

307.7

1074

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

43.9

307.7

709

174

XA400

NOMESCO Finland

EEG

22.1

307.7

259

120

G40.89

ICD-10 Finland

Other epilepsy

4257.0

307.7

418

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

16.4

307.7

473

303

R56.8

ICD-10 Finland

Other and unspecified convulsions

43.4

307.7

3748

1398

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

307.7

7943

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

17.4

307.7

532

322

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

307.7

1022

N03AX14

ATC

levetiracetam; systemic

247.5

307.7

3865

261

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

29.4

307.7

280

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

+∞

307.7

425

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

5401.8

307.7

522

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

10.4

307.7

573

582

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

8.8

307.7

924

1144

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

13.5

307.7

336

258

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.0

307.7

1957

4669

N03AX15

ATC

zonisamide; oral

59.7

307.7

199

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.4

307.7

2897

10928

N03AX18

ATC

lacosamide; systemic

1134.0

307.7

1192

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.6

307.7

1640

5262

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

3479.7

307.7

346

N03AX23

ATC

brivaracetam; systemic

+∞

307.7

355

N88

ICPC

Epilepsy

868.1

307.7

724

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

3166.5

307.7

615

G40.9

ICD-10 Finland

Epilepsy, unspecified

1891.4

307.7

3849

N05BA01

ATC

diazepam; systemic, rectal

3.4

307.7

1927

6561

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

7.7

307.7

2397

3975

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

307.7

3514

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

+∞

307.7

4015

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

+∞

307.7

416

N03AB02

ATC

phenytoin; systemic

56.9

307.7

688

130

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

5368.7

307.7

988

XA800

NOMESCO Finland

Neuropsychological investigation

7.6

307.7

1182

1749

N03AX11

ATC

topiramate; oral

7.5

307.7

536

746

AA1AD

NOMESCO Finland

CT of head and brain

5.1

307.7

5208

18128

ZXC95

NOMESCO Finland

Use of surgical navigator

11.6

307.7

385

344

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

89.4

307.7

244

N03AX09

ATC

lamotrigine; oral

8.1

307.7

1284

1788

G41.9

ICD-10 Finland

Status epilepticus, unspecified

117.6

307.7

470

H02AB02

ATC

dexamethasone; systemic

3.0

307.3

1538

5657

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.3

301.3

1249

4106

G41.0

ICD-10 Finland

Grand mal status epilepticus

151.3

298.9

149

K90

ICPC

Stroke/cerebrovascular accident

5.5

294.0

590

1126

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

12.9

293.5

285

227

R55

ICD-10 Finland

Syncope and collapse

2.9

283.2

1565

6063

G41.2

ICD-10 Finland

Complex partial status epilepticus

95.4

270.7

141

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

6.0

270.6

492

855

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

7.9

268.7

375

492

C71.2

ICD-10 Finland

Malignant neoplasm: Temporal lobe

115.8

268.5

137

T90.5

ICD-10 Finland

Sequelae of intracranial injury

9.7

265.4

312

330

Z2445

NOMESCO Finland

Psychologist

4.4

264.8

709

1720

3454A

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]

+∞

262.7

251

C71.1

ICD-10 Finland

Malignant neoplasm: Frontal lobe

78.9

262.3

140

R41.0

ICD-10 Finland

Disorientation, unspecified

5.0

258.9

586

1241

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

9.9

256.5

298

310

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

14.4

250.9

228

162

C71.13

ICD-10 Finland

Malignant tumor of frontal lobe grade IV glioma

82.3

245.0

130

N03AE01

ATC

clonazepam; systemic

3.7

243.3

837

2428

C71.23

ICD-10 Finland

Malignant tumor of temporal lobe grade IV glioma

76.9

240.8

129

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

1187.3

238.3

232

7803A

ICD-9 Finland

General symptoms, Convulsions

11.7

236.1

243

212

N07

ICPC

Convulsion/seizure

36.8

233.5

145

AA1BD

NOMESCO Finland

Extensive CT of head and brain

5.6

231.5

450

832

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

30.9

227.9

149

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

13.6

226.1

212

159

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

4.5

225.8

569

1314

N03AX22

ATC

perampanel; oral

2055.4

218.3

211

R47.0

ICD-10 Finland

Dysphasia and aphasia

9.5

215.7

258

279

R4150

NOMESCO Finland

Neuropsychological rehabilitation

11.7

211.2

218

191

H53.4

ICD-10 Finland

Visual field defects

5.6

206.5

401

740

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

4.0

205.4

615

1616

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

6.8

198.9

317

481

TAB00

NOMESCO Finland

Lumbar puncture

3.7

198.2

660

1867

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.2

192.2

1891

9468

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.7

190.9

1180

4786

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

6.4

189.8

321

518

N18

ICPC

Paralysis/weakness

5.4

188.3

377

715

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

7.1

183.2

280

406

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

34.6

178.9

113

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

21.9

178.6

132

130

Kela drug reimbursment

Malignant tumour

2.6

177.2

1117

4566

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

5.5

176.9

351

660

34532

ICD-8 Finland

Epilepsy, Partialis (focalis) generalisata

+∞

176.6

169

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

174.6

3339

21138

34599

ICD-8 Finland

Epilepsy, Other and unspecified

+∞

174.5

167

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

8.4

174.4

228

276

A28

ICPC

Limited function/disability NOS

2.1

174.0

2031

10830

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

10.3

173.8

195

193

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

6.1

168.5

297

499

S06.3

ICD-10 Finland

Focal brain injury

6.8

167.8

266

401

78020

ICD-8 Finland

Certain symptoms referable to nervous system and special senses, Convulsions

9.2

166.1

202

223

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.7

165.7

998

3983

3454B

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[TEMPORAALIEPILEPTINEN POISSAOLOKOHTAUS]

+∞

165.0

158

34530

ICD-8 Finland

Epilepsy, Psychomotorica

+∞

164.0

157

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

164.0

2836

17307

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

14.9

163.0

145

ZXC40

NOMESCO Finland

Use of ultrasound

10.5

160.7

178

173

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

21.7

159.0

118

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

8.7

154.2

196

229

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

7.9

153.9

213

276

R4120

NOMESCO Finland

Occupational therapy

2.8

153.6

831

3133

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.9

153.1

792

2916

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

+∞

152.5

146

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

9.0

152.1

188

212

N05AX08

ATC

risperidone; systemic

2.5

151.8

1043

4429

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

12.7

147.8

144

115

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.4

147.4

548

1661

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

5.6

142.5

274

500

WX892

NOMESCO Finland

Monitored bed care

2.6

140.6

924

3836

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

6.7

140.4

225

343

D43.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, unspecified

23.8

138.4

G40.0

ICD-10 Finland

Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset

1368.3

137.8

134

3459X

ICD-9 Finland

Epilepsy, unspecified

+∞

133.6

128

AAK00

NOMESCO Finland

Cranioplasty

42.4

133.5

D32.01

ICD-10 Finland

Benign tumor of meninges on interhemispheric surface

12.7

132.4

129

103

WX882

NOMESCO Finland

High dependency care

3.6

132.3

464

1353

C71.30

ICD-10 Finland

Malignant tumor in parietal lobe without histology

51.0

132.0

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.4

131.2

501

1543

S06.0

ICD-10 Finland

Concussion

2.2

130.7

1249

6102

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.5

129.9

862

3590

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

36.2

126.5

9440/3-C71.9

ICD-O-3

Glioblastoma, NOS, of brain, NOS

46.6

126.1

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

123.5

1666

9238

F05.9

ICD-10 Finland

Delirium, unspecified

4.2

121.7

334

820

N06AB04

ATC

citalopram; systemic

1.9

120.3

1993

11816

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

+∞

120.0

115

R51.80

ICD-10 Finland

Headache

2.0

118.5

1613

8960

N05AH04

ATC

quetiapine; oral

1.9

117.9

1793

10334

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.1

117.5

513

1712

K91

ICPC

Cerebrovascular disease

5.3

117.0

238

457

C71.12

ICD-10 Finland

Malignant tumor of frontal lobe grade III glioma

204.1

116.8

121

L28

ICPC

Limited function/disability (L)

1.9

116.1

1933

11461

9440/3-C71.2

ICD-O-3

Glioblastoma, NOS, of temporal lobe

64.4

115.9

AAF00

NOMESCO Finland

Ventriculostomy

9.4

114.5

137

148

N03AG04

ATC

vigabatrin; oral

+∞

111.6

107

W19

ICD-10 Finland

Unspecified fall

2.2

111.6

1112

5504

R53

ICD-10 Finland

Malaise and fatigue

1.7

109.7

2533

16501

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

109.6

4524

34179

N74

ICPC

Malignant neoplasm nervous system

36.0

108.7

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

5.4

108.5

218

414

N03AF04

ATC

eslicarbazepine; oral

+∞

108.5

104

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

108.2

1313

6990

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.6

107.5

679

2755

G41.8

ICD-10 Finland

Other status epilepticus

42.9

107.0

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

11.1

106.5

113

103

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.8

105.0

332

902

Z51.5

ICD-10 Finland

Palliative care

2.2

104.4

968

4650

ZX050

NOMESCO Finland

Stereotactic radiotherapy

6.8

103.9

164

246

SPAT1229

SPAT

Assessment of need for aid

2.3

103.1

817

3675

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

6.3

102.2

173

279

N05BA04

ATC

oxazepam; oral

1.7

101.9

2465

16205

R40.2

ICD-10 Finland

Coma, unspecified

6.7

101.0

160

241

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

7.4

100.9

147

202

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.3

100.6

799

3596

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

3.3

100.2

395

1239

WX872

NOMESCO Finland

Intensive care

2.6

99.5

591

2325

SPAT1216

SPAT

Assessment of functional ability

1.9

98.5

1519

8744

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

6.4

98.4

163

257

PA6AD

NOMESCO Finland

CT of neck arteries

3.0

97.8

460

1600

A06AD11

ATC

lactulose; oral

1.9

97.6

1490

8548

S06.2

ICD-10 Finland

Diffuse brain injury

5.9

97.2

175

300

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

14.9

97.2

C71.33

ICD-10 Finland

Malignant tumor of parietal lobe grade IV glioma

55.3

96.9

G91.0

ICD-10 Finland

Communicating hydrocephalus

9.2

94.2

114

125

R4130

NOMESCO Finland

Speech therapy

3.4

93.8

353

1075

N28

ICPC

Limited function/disability (N)

4.2

93.8

255

621

C71.3

ICD-10 Finland

Malignant neoplasm: Parietal lobe

49.3

93.0

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.3

92.2

715

3181

R42

ICD-10 Finland

Dizziness and giddiness

1.7

92.1

2210

14437

C71.21

ICD-10 Finland

Malignant tumor of temporal lobe grade II glioma

191.8

91.4

A04AA02

ATC

granisetron; systemic, transdermal

2.4

90.5

652

2808

N05AH03

ATC

olanzapine; systemic

2.4

90.4

665

2890

Z2446

NOMESCO Finland

Social worker

2.3

89.9

733

3331

WX730

NOMESCO Finland

Conventional respirator

4.4

89.6

228

528

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

89.1

1302

7349

N02AA05

ATC

oxycodone; systemic

1.8

88.7

1767

10952

181

Kela drug reimbursment

Retigabine and vigabatrin

+∞

87.6

ADB00

NOMESCO Finland

Implantation of vagus nerve stimulating device

+∞

87.6

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

87.6

1136

6160

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

10.0

86.9

100

N76

ICPC

Neoplasm nervous system unspecified

26.2

86.9

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.6

86.7

530

2112

N19

ICPC

Speech disorder

4.1

86.7

241

597

AA5PD

NOMESCO Finland

CT examination of brain pefusion

5.7

86.0

160

283

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

5.1

86.0

182

362

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

85.8

1996

12899

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

85.7

1463

8659

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

85.3

2113

13878

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

83.7

729

3403

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.1

83.7

369

1236

S01.0

ICD-10 Finland

Open wound of scalp

2.1

83.6

853

4239

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.4

83.4

623

2724

N29

ICPC

Neurological sympt/complt other

3.7

83.2

266

728

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

4.0

83.0

241

616

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

82.8

1527

9241

N03AX25

ATC

cenobamate; oral

+∞

82.4

XX3DW

NOMESCO Finland

Time consuming IT work

2.0

81.9

1027

5498

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

8.2

81.8

109

135

C71.00

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles without histology

27.6

81.1

34510

ICD-8 Finland

Epilepsy, """"Grand mal""""

+∞

79.3

A86

ICD-10 Finland

Unspecified viral encephalitis

8.6

78.9

101

119

PA2AD

NOMESCO Finland

CT angiography of brain

5.7

78.3

146

259

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

76.7

1293

7606

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

76.5

1123

6327

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

10.0

76.3

SPAT1234

SPAT

Support of social functional capacity

2.4

76.2

563

2448

R56.0

ICD-10 Finland

Febrile convulsions

8.4

75.7

117

34539

ICD-8 Finland

Epilepsy, Partialis (focalis) NUD

+∞

75.1

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.5

75.1

510

2135

XCK00

NOMESCO Finland

Perimetry

2.3

75.0

629

2888

WF002

NOMESCO Finland

Radical radiotherapy

2.3

74.8

589

2633

N05CF01

ATC

zopiclone; oral

1.5

74.3

2832

20497

C71.22

ICD-10 Finland

Malignant tumor of temporal lobe grade III glioma

194.0

74.2

ZXD05

NOMESCO Finland

Urgent procedure

1.5

72.7

2702

19426

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

72.2

792

4036

G80.2

ICD-10 Finland

Spastic hemiplegic cerebral palsy

22.7

71.3

3069, ,

Kela drug reimbursment

+∞

70.9

1541, ,

Kela drug reimbursment

+∞

70.9

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

8.5

70.7

108

R1260

NOMESCO Finland

Evaluation of communicative skills

3.9

70.1

212

558

SPAT1254

SPAT

Administration of medicine

1.7

70.1

1440

8946

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

9.6

70.0

H47.2

ICD-10 Finland

Optic atrophy

8.3

70.0

112

N05AA02

ATC

levomepromazine; systemic

2.6

69.7

408

1590

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.8

69.3

216

581

9530/0-C70.9

ICD-O-3

Meningioma, NOS, of meninges, NOS

13.0

69.0

F80.1

ICD-10 Finland

Expressive language disorder

4.7

68.3

160

347

M03BX01

ATC

baclofen; systemic

3.6

67.5

227

643

C03CA01

ATC

furosemide; systemic

1.5

66.3

2734

20021

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

10.7

66.2

N06AX11

ATC

mirtazapine; oral

1.5

66.1

2988

22297

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.8

65.1

149

317

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

11.0

64.9

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.1

64.7

673

3358

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

+∞

64.6

AAA10

NOMESCO Finland

Biopsy through craniotomy

22.5

64.2

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

64.1

1776

11885

AAD05

NOMESCO Finland

Evacuation of acute subdural haematoma

8.0

63.8

108

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

14.8

63.0

N05BA06

ATC

lorazepam; systemic, sublingual

2.3

62.5

502

2261

PA7BD

NOMESCO Finland

CT angiography of neck and brain

3.7

61.7

197

539

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

4.7

61.1

142

306

N06AB10

ATC

escitalopram; oral

1.6

60.4

1756

11868

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

8.4

60.4

P20

ICPC

Memory disturbance

1.7

60.0

1277

7984

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

4.3

59.6

153

357

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

4.5

59.2

145

326

ZXM40

NOMESCO Finland

Use of fluorescent substance

17.0

59.1

N99

ICPC

Neurological disease other

4.0

59.0

169

428

AWC00

NOMESCO Finland

Reoperation of nervous system because of deep wound infection in the nervous system

25.7

58.8

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.0

58.8

263

888

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

13.5

58.7

Z3231

NOMESCO Finland

Registered nurse

1.5

58.6

2450

17903

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

58.5

1624

10850

N05CD07

ATC

temazepam; oral

1.8

58.1

1006

5933

AAB30

NOMESCO Finland

Evacuation of spontaneous intracranial haematoma

15.1

57.9

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

3.8

57.7

179

480

AAJ20

NOMESCO Finland

Excision of epileptic focus

+∞

57.3

3454X

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[ALII DISTURBATIONES CONSCIENTAE EPILEPTICI]

+∞

57.3

I69.2

ICD-10 Finland

Sequelae of other nontraumatic intracranial haemorrhage

12.2

57.3

G40.7

ICD-10 Finland

Petit mal, unspecified, without grand mal seizures

197.8

57.0

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.3

56.9

471

2146

R50.9

ICD-10 Finland

Fever, unspecified

1.6

56.6

1446

9461

R46.8

ICD-10 Finland

Other symptoms and signs involving appearance and behaviour

16.9

56.5

SPAT1301

SPAT

No procedures

1.5

56.4

2740

20595

R90.0

ICD-10 Finland

Intracranial space-occupying lesion

16.1

56.3

D32.04

ICD-10 Finland

Secondary or multiple benign tumor of the meninges above the exam

22.9

56.3

S06.4

ICD-10 Finland

Epidural haemorrhage

13.3

56.1

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.5

55.8

362

1481

C71.19

ICD-10 Finland

Malignant tumor of frontal lobe other or unspecified histology

102.3

55.8

34533

ICD-8 Finland

Epilepsy, Partialis (focalis) alia

+∞

55.2

R41.3

ICD-10 Finland

Other amnesia

2.7

55.0

314

1208

AAA27

NOMESCO Finland

Insertion of intracerebral pressure monitoring device

17.4

54.9

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.1

53.5

223

723

WF003

NOMESCO Finland

Adjuvant radiotherapy

2.5

53.4

333

1337

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

3.9

53.3

157

406

Z3226

NOMESCO Finland

Physiotherapist

1.6

53.0

1583

10729

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

52.8

732

4029

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.2

52.8

209

657

R11

ICD-10 Finland

Nausea and vomiting

1.8

52.6

839

4824

3455A

ICD-9 Finland

Epilepsy, Partial epilepsy, without mention of impairment of consciousness

+∞

52.1

G91.1

ICD-10 Finland

Obstructive hydrocephalus

7.5

52.0

C71.29

ICD-10 Finland

Malignant tumor in temporal lobe other or unspecified histology

83.4

51.9

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

51.9

1223

7829

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

51.8

1386

9153

AAD15

NOMESCO Finland

Evacuation of traumatic intracerebral haematoma

18.7

51.7

B01AC04

ATC

clopidogrel; oral

1.6

51.5

1442

9623

R4110

NOMESCO Finland

Physiotherapy

1.5

51.2

2396

17818

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

10.8

51.2

AA5FG

NOMESCO Finland

Functional MRI examination of brain with high intensity magnet

262.0

51.1

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

50.4

531

2658

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

50.3

1978

14207

D32.03

ICD-10 Finland

Benign meningioma in ventricles

14.6

50.1

N05AD01

ATC

haloperidol; systemic

2.5

49.9

312

1255

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

49.5

2206

16235

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

13.6

49.3

I60.0

ICD-10 Finland

Subarachnoid haemorrhage from carotid siphon and bifurcation

8.4

48.8

OAB43, ,

SPAT

0.6

48.5

1287

18817

H02AB09

ATC

hydrocortisone; systemic

2.7

48.4

268

1015

R1250

NOMESCO Finland

Evaluation of functional capability

2.7

48.4

263

987

9440/3-C71.1

ICD-O-3

Glioblastoma, NOS, of frontal lobe

62.5

48.2

A02BC02

ATC

pantoprazole; systemic

1.4

48.0

5928

51757

B01AA03

ATC

warfarin; systemic

1.5

48.0

1657

11571

RS222, ,

NOMESCO Finland

3.7

47.9

150

405

P85

ICPC

Mental retardation

8.7

47.8

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

47.7

431

2035

ZXY02

NOMESCO Finland

Neuropsychologist

5.9

47.2

146

N03AX12

ATC

[U] gabapentin; oral

1.6

47.1

1327

8855

G40.59

ICD-10 Finland

Other special epileptic syndromes

+∞

46.9

N02BE01

ATC

paracetamol; systemic, rectal

1.5

46.7

8032

74137

G72.8

ICD-10 Finland

Other specified myopathies

3.3

46.3

179

555

G81.1

ICD-10 Finland

Spastic hemiplegia

12.5

46.0

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

10.2

45.7

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.2

45.6

183

580

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

45.5

816

4847

I61.8

ICD-10 Finland

Other intracerebral haemorrhage

8.9

45.4

G80.1

ICD-10 Finland

Spastic diplegic cerebral palsy

16.6

45.2

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

45.0

564

2999

9400/3-C71.1

ICD-O-3

Astrocytoma, NOS, of frontal lobe

231.0

45.0

R25.2

ICD-10 Finland

Cramp and spasm

2.7

44.9

250

950

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.3

44.8

341

1499

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

3.7

44.8

145

401

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.9

44.7

209

724

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.0

44.4

204

700

I63.8

ICD-10 Finland

Other cerebral infarction

4.1

44.3

123

305

G06.0

ICD-10 Finland

Intracranial abscess and granuloma

14.3

44.2

A04AA01

ATC

ondansetron; systemic, rectal

1.8

44.1

713

4109

4380A

ICD-9 Finland

Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]

6.7

44.0

103

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.2

43.9

115

273

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.3

43.9

332

1456

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

4.1

43.9

119

290

A04

ICPC

Weakness/tiredness general

1.5

43.7

1438

9920

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

43.7

1631

11553

R25.1

ICD-10 Finland

Tremor, unspecified

2.4

43.5

311

1330

F83

ICD-10 Finland

Mixed specific developmental disorders

4.7

43.3

211

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

43.2

2946

23278

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.1

42.8

406

1952

G40.80

ICD-10 Finland

Epilepsy with continuous EEG spike-waves during slow wave sleep

+∞

42.7

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

5.7

42.3

137

SPAT1240

SPAT

Therapeutic discussion

1.7

42.2

852

5225

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

42.0

1321

18726

I60.8

ICD-10 Finland

Other subarachnoid haemorrhage

9.8

41.8

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

41.8

549

2965

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

40.5

372

1766

2161

FHL

Neck ligation, big brain

7.9

40.4

WYA20

NOMESCO Finland

Home visit

2.8

40.2

203

733

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.9

40.2

118

305

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

39.9

2678

21045

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

6.8

39.8

G40.50

ICD-10 Finland

Epilepsia partialis continua [Kozhevnikof]

+∞

39.6

ZXD35

NOMESCO Finland

Usual procedure

2.3

39.5

299

1312

2152

FHL

Extraction, big brain

12.2

39.2

C71.31

ICD-10 Finland

Malignant tumor of the parietal lobe grand II glioma

137.2

38.7

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.9

38.7

187

660

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.7

38.6

215

817

B01AC07

ATC

dipyridamole; systemic

2.1

38.6

396

1961

GBB00

NOMESCO Finland

Tracheostomy

3.6

38.6

128

360

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

12.8

38.3

N05AF03

ATC

chlorprothixene; systemic

2.6

38.1

227

892

OAA67, ,

SPAT

0.6

37.8

553

9433

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

9.1

37.7

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

5.9

37.6

114

AAJ99

NOMESCO Finland

Other operation for epilepsy

+∞

37.5

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

8.5

37.3

F03

ICD-10 Finland

Unspecified dementia

2.0

37.2

388

1934

R5110, ,

SPAT

1.7

37.0

723

4389

F05.8

ICD-10 Finland

Other delirium

4.2

37.0

235

PA2AC

NOMESCO Finland

Cerebral angiography with X-ray

5.8

37.0

116

9450/3-C71.1

ICD-O-3

Oligodendroglioma, NOS, of frontal lobe

190.7

36.8

H53.2

ICD-10 Finland

Diplopia

2.2

36.5

298

1350

34598

ICD-8 Finland

Epilepsy, Alia definita

+∞

36.5

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

36.2

314

1458

I61

ICD-10 Finland

Intracerebral haemorrhage

11.2

36.2

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

12.5

35.7

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

35.5

364

1803

I95.1

ICD-10 Finland

Orthostatic hypotension

2.1

35.2

364

1808

N06AX16

ATC

venlafaxine; oral

1.5

35.0

1101

7494

N03AX16

ATC

[U] pregabalin

1.4

35.0

1807

13542

9400/3-C71.9

ICD-O-3

Astrocytoma, NOS, of brain, NOS

180.6

34.7

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

34.7

2242

17439

AAC40

NOMESCO Finland

Extirpation of intracranial arterio-venous malformation

57.3

34.2

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

4.2

34.0

220

N03AG06

ATC

tiagabine; oral

338.3

33.9

C71.32

ICD-10 Finland

Malignant tumor of parietal lobe grade III glioma

338.3

33.9

4300A

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]

6.6

33.9

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

33.8

723

4492

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

33.5

1175

8181

G40.8

ICD-10 Finland

Other epilepsy

+∞

33.3

SPAT1053

SPAT

Memory test

1.5

33.3

1120

7727

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

2.9

33.3

155

536

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.1

33.3

339

1674

G45.4

ICD-10 Finland

Transient global amnesia

2.5

33.1

207

833

U04

ICPC

Incontinence urine

1.8

32.8

496

2798

Z75.5

ICD-10 Finland

Holiday relief care

4.0

32.7

235

S22.3

ICD-10 Finland

Fracture of rib

1.7

32.7

617

3708

N07BB01

ATC

disulfiram; oral

2.0

32.5

349

1757

Q04.8

ICD-10 Finland

Other specified congenital malformations of brain

48.9

32.5

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

32.4

616

3709

JN4AD

NOMESCO Finland

Body CT examination

1.5

32.4

952

6378

G83.8

ICD-10 Finland

Other specified paralytic syndromes

12.3

32.3

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.8

32.3

264

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

32.3

3134

25838

N05AX12

ATC

aripiprazole; systemic

2.1

32.2

332

1647

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

6.7

32.2

Y86

ICD-10 Finland

Sequelae of other accidents

5.6

32.1

107

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

31.9

952

6402

N06AB06

ATC

sertraline; oral

1.6

31.7

903

6007

C08CA01

ATC

amlodipine; oral

1.3

31.7

3117

25725

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.9

31.4

148

516

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

5.4

31.4

113

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

31.3

371

1934

AAJ15

NOMESCO Finland

Hippocampectomy

+∞

31.3

F10.24

ICD-10 Finland

Alcohol depence active use

2.9

31.2

148

518

SPAT1252

SPAT

Overall medication plan or its review

1.7

31.2

544

3200

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.9

31.1

396

2115

B01AB05

ATC

enoxaparin; parenteral

1.3

31.1

2479

19851

N30.0

ICD-10 Finland

Acute cystitis

1.4

30.8

1349

9793

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

30.7

952

6450

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

12.0

30.7

F44.5

ICD-10 Finland

Dissociative convulsions

85.3

30.7

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

30.7

423

2318

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

4.6

30.7

157

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

3.6

30.6

100

279

ZX095

NOMESCO Finland

Combined chemoradiotherapy

4.4

30.5

178

G93.0

ICD-10 Finland

Cerebral cysts

5.4

30.4

109

E87.6

ICD-10 Finland

Hypokalaemia

2.1

30.4

298

1452

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

9.1

30.3

N05AB03

ATC

perphenazine; systemic, rectal

2.1

30.3

281

1341

G40.52

ICD-10 Finland

Epileptic seizures related to drugs

+∞

30.2

ZY010

NOMESCO Finland

Hospital outpatient

1.8

30.1

438

2441

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2.1

30.1

293

1424

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

2.3

30.1

232

1027

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

29.9

1553

11614

S00.0

ICD-10 Finland

Superficial injury of scalp

2.3

29.9

228

1005

A29

ICPC

General symptom/complaint other

1.5

29.8

1130

7976

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

2.9

29.8

144

509

A41.9

ICD-10 Finland

Sepsis, unspecified

2.0

29.7

318

1600

C71.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of brain

45.1

29.6

JN4BD

NOMESCO Finland

Extensive body CT

1.6

29.5

809

5333

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

5.5

29.5

105

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

29.5

1079

7565

R40.0

ICD-10 Finland

Somnolence

5.5

29.3

102

F01.9

ICD-10 Finland

Vascular dementia, unspecified

2.8

29.2

145

520

S02.11

ICD-10 Finland

Fracture of base of skull, open

6.1

29.2

AA9CW, ,

NOMESCO Finland

9.2

29.1

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.5

29.1

178

710

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.5

28.9

280

Q85.1

ICD-10 Finland

Tuberous sclerosis

66.1

28.9

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

5.7

28.6

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

4.2

28.4

184

N05AH02

ATC

clozapine; systemic

2.7

28.0

155

589

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

3.5

27.7

269

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

27.7

514

3075

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

7.5

27.5

R47.1

ICD-10 Finland

Dysarthria and anarthria

3.3

27.5

102

309

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

27.5

628

3964

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.9

27.4

358

1928

G41.1

ICD-10 Finland

Petit mal status epilepticus

35.1

27.4

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.1

27.2

115

377

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

27.2

2322

18712

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.7

26.9

143

532

F70.9

ICD-10 Finland

Mild mental retardation, Without mention of impairment of behaviour

9.7

26.7

F06.32

ICD-10 Finland

Organic depression

6.9

26.7

C71.01

ICD-10 Finland

Malignant tumor of cerebellum except lobes and ventricles grade II glioma

140.4

26.6

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

26.6

6148

55986

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.9

26.6

123

425

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

5.0

26.5

112

C02AC05

ATC

moxonidine; oral

1.8

26.4

372

2052

N04AA02

ATC

biperiden; systemic

2.6

26.4

156

612

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.0

26.4

117

395

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.7

26.3

459

2700

D33.9

ICD-10 Finland

Benign neoplasm: Central nervous system, unspecified

10.4

26.2

WX704

NOMESCO Finland

Intubation

1.6

26.0

652

4209

N06AX22

ATC

agomelatine; oral

2.3

25.9

193

842

Y0209

ICD-8 Finland

Examination of the nervous system and sensory organs, Nervous system

4.1

25.9

171

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

6.0

25.9

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

25.8

600

3804

PA2LT

NOMESCO Finland

Endovascular closure of extensive brain aneurysm

5.8

25.8

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

25.7

547

3391

H03AA01

ATC

levothyroxine sodium; systemic

1.4

25.6

1692

13119

S06.9

ICD-10 Finland

Intracranial injury, unspecified

3.8

25.5

204

PA2KT

NOMESCO Finland

Endovascular closure of brain aneurysm

7.3

25.4

F07.2

ICD-10 Finland

Postconcussional syndrome

8.7

25.4

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

3.3

25.4

290

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

2.3

25.3

199

889

-, ,

ICD-10 Finland

2.3

25.3

191

839

9440/3-C71.3

ICD-O-3

Glioblastoma, NOS, of parietal lobe

50.1

25.2

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.2

25.1

219

1020

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

3.9

25.1

188

RL140, ,

NOMESCO Finland

6.4

25.1

43090

ICD-8 Finland

Subarachnoid haemorrhage, Postaneurysma sacculare, hypertonia non indicata

8.9

25.0

G40.01

ICD-10 Finland

Pediatric epilepsy with occipital EEG paroxysms

+∞

25.0

C71.40

ICD-10 Finland

Malignant tumor of the occipital lobe without histology

58.1

25.0

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.9

24.9

120

424

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

24.8

382

2167

G05.1*B00.4

ICD-10 Finland

Herpesviral meningoencephalitis

21.2

24.7

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

24.6

405

2342

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

3.9

24.5

187

N80

ICPC

Head injury other

2.2

24.5

202

921

AAF15

NOMESCO Finland

Ventriculoatrial shunt

6.2

24.4

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.3

24.3

273

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

24.3

412

2404

AAK80

NOMESCO Finland

Partial excision of skull cap

20.1

24.2

C71.83

ICD-10 Finland

Overall malignant tumor of the brain grade IV glioma

56.1

24.0

R4120, ,

SPAT

2.7

24.0

130

489

D21

ICPC

Swallowing problem

2.5

24.0

145

576

Z50.5

ICD-10 Finland

Speech therapy

2.6

23.9

143

565

C07AA05

ATC

propranolol; systemic

1.4

23.9

1483

11378

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.5

23.8

739

5003

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.6

23.7

138

538

Z00.0

ICD-10 Finland

General medical examination

1.3

23.6

1551

12005

P15

ICPC

Chronic alcohol abuse

2.0

23.5

246

1229

P29

ICPC

Psychological sympt/compl other

1.6

23.5

596

3857

OAB48, ,

SPAT

0.6

23.4

612

9138

F71.0

ICD-10 Finland

Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour

19.5

23.4

S02.00

ICD-10 Finland

Fracture of the upper part of the head closed

4.9

23.3

105

RS122, ,

NOMESCO Finland

5.4

23.3

N06AX03

ATC

mianserin; oral

1.8

23.3

355

2008

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.5

23.3

776

5330

I60.2

ICD-10 Finland

Subarachnoid haemorrhage from anterior communicating artery

4.4

23.1

130

P72

ICPC

Schizophrenia

2.4

23.0

159

672

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

8.0

23.0

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.8

23.0

347

1957

W10

ICD-10 Finland

Fall on and from stairs and steps

1.7

23.0

423

2525

SPAT1304

SPAT

Counselling and guidance related to ageing

1.6

23.0

546

3479

C07AB07

ATC

bisoprolol; oral

1.2

22.9

3907

34110

C10AA01

ATC

simvastatin; oral

1.3

22.9

3213

27441

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

4.0

22.8

165

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.0

22.8

101

341

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

22.8

457

2790

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

3.4

22.7

235

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

2.7

22.7

117

429

E86

ICD-10 Finland

Volume depletion

2.1

22.7

212

1016

OAA80, ,

SPAT

0.6

22.7

303

5336

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

5.9

22.5

F70.1

ICD-10 Finland

Mild mental retardation, Significant impairment of behaviour requiring attention or treatment

7.8

22.5

R33

ICD-10 Finland

Retention of urine

1.5

22.5

651

4340

A07

ICPC

Coma

4.3

22.4

137

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

22.4

1023

7455

N05AD03

ATC

melperone; systemic

2.8

22.4

109

388

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.8

22.3

327

1828

M01AH05

ATC

etoricoxib; oral

0.8

22.3

3968

44724

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.3

22.3

164

713

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

4.2

22.3

142

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

22.3

809

5651

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.3

22.3

253

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.4

22.2

152

640

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

22.1

559

3613

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.9

22.1

278

1480

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

22.1

2392

19789

I60.3

ICD-10 Finland

Subarachnoid haemorrhage from posterior communicating artery

7.9

22.1

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.9

22.0

263

1376

J01DB01

ATC

cefalexin; oral

1.3

22.0

7222

67618

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.7

22.0

428

2593

34500

ICD-8 Finland

Epilepsy, """"Petit mal""""

+∞

21.9

9450/3-C71.9

ICD-O-3

Oligodendroglioma, NOS, of brain, NOS

+∞

21.9

RS221, ,

NOMESCO Finland

2.5

21.7

130

514

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

21.7

868

6176

SPAT1172

SPAT

Guidance concerning hydration

2.1

21.5

191

898

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

3.1

21.4

295

RT150, ,

NOMESCO Finland

4.5

21.4

117

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.5

21.3

136

555

X58

ICD-10 Finland

Exposure to other specified factors

1.4

21.3

1179

8874

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

21.2

684

4663

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

21.1

938

6802

I61.4

ICD-10 Finland

Intracerebral haemorrhage in cerebellum

6.1

21.1

R60.0

ICD-10 Finland

Localized oedema

1.4

21.0

991

7260

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

3.1

21.0

283

I68.0*E85.9

ICD-10 Finland

Cerebral amyloid angiopathy

8.5

21.0

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.6

20.9

498

3174

J01EA01

ATC

trimethoprim; systemic

1.3

20.9

1881

15185

ZXA05

NOMESCO Finland

Left side

1.3

20.9

1831

14731

G04.8

ICD-10 Finland

Other encephalitis, myelitis and encephalomyelitis

16.5

20.9

S72.0

ICD-10 Finland

Fracture of neck of femur

1.8

20.8

320

1814

AAJ10

NOMESCO Finland

Lobectomy for epilepsy

+∞

20.8

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

3.7

20.8

181

D33.05

ICD-10 Finland

Other lateral benign tumor in temporal lobe

24.2

20.8

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

3.7

20.7

177

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

1.8

20.7

286

1570

N06DA03

ATC

rivastigmine; oral, transdermal

1.7

20.7

348

2027

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

3.5

20.6

201

Z43.0

ICD-10 Finland

Attention to tracheostomy

8.7

20.6

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

3.9

20.6

155

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

20.6

174

802

F06.7

ICD-10 Finland

Mild cognitive disorder

1.9

20.6

242

1261

AAU00

NOMESCO Finland

Removal of implant or external fixation device from skull

110.2

20.6

EBA00

NOMESCO Finland

Extraction of tooth

1.2

20.6

2968

25355

C71.80

ICD-10 Finland

Overall malignant tumor of the brain without histology

30.1

20.5

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.2

20.5

179

836

XF404

NOMESCO Finland

Ambulatory ECG

1.5

20.5

660

4499

XX3XW, ,

NOMESCO Finland

3.7

20.5

174

SPAT1260

SPAT

Consultation of another employee

1.3

20.5

1327

10230

SPAT1167

SPAT

Insertion of urinary catheter

1.9

20.3

255

1358

K59.0

ICD-10 Finland

Constipation

1.6

20.2

453

2845

G93.4

ICD-10 Finland

Encephalopathy, unspecified

5.7

20.2

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

20.2

1004

7421

S18

ICPC

Laceration/cut

1.2

20.1

3845

33821

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.1

20.1

189

908

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.0

20.1

208

1036

WF004

NOMESCO Finland

Palliative radiotherapy

2.2

20.0

175

818

113

Kela drug reimbursment

Anxiety disorders associated with mental retardation

6.8

19.9

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

7.0

19.9

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

19.9

482

3085

C71.39

ICD-10 Finland

Malignant tumor of parietal lobe other or unspecified histology

57.6

19.9

N27

ICPC

Fear of neurological disease other

2.3

19.9

150

660

F72.0

ICD-10 Finland

Severe mental retardation, with the statement of no, or minimal, impairment of behaviour

35.8

19.8

AAA35

NOMESCO Finland

Insertion of subdural electrodes

+∞

19.8

34531

ICD-8 Finland

Epilepsy, Patrialis (focalis) Jackson

+∞

19.8

P99

ICPC

Psychological disorders other

1.9

19.8

236

1236

AA1AA

NOMESCO Finland

Head X-ray examination

3.1

19.7

262

N05CD02

ATC

nitrazepam; oral

2.4

19.7

128

527

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

3.1

19.7

273

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

19.6

307

1750

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

19.6

864

6251

R56

ICD-10 Finland

Convulsions, not elsewhere classified

28.9

19.6

ZXA00

NOMESCO Finland

Right side

1.3

19.5

1957

16003

G80.0

ICD-10 Finland

Spastic quadriplegic cerebral palsy

24.6

19.5

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.8

19.5

361

G80.9

ICD-10 Finland

Cerebral palsy, unspecified

19.4

G44.2

ICD-10 Finland

Tension-type headache

1.4

19.4

987

7320

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

19.3

551

3659

I60.7

ICD-10 Finland

Subarachnoid haemorrhage from intracranial artery, unspecified

4.7

19.3

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.2

19.2

160

733

WZC30

NOMESCO Finland

Teaching

1.3

19.2

1263

9747

N05BA02

ATC

chlordiazepoxide; systemic

2.1

19.2

176

838

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

19.2

1951

15973

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.0

19.2

221

1144

SPAT1263

SPAT

Sampling

1.2

19.2

3322

28886

RS211, ,

NOMESCO Finland

4.3

19.2

115

S02.10

ICD-10 Finland

Fracture of base of skull, closed

4.3

19.1

111

AAL10

NOMESCO Finland

Intracranial endovascular thrombolysis

3.6

19.1

173

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.6

19.0

414

2581

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

19.0

419

2620

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.7

19.0

315

1827

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.6

19.0

397

2452

D32.07

ICD-10 Finland

Secondary or multiple benign tumor of the meninges below the exam

14.8

18.9

N06AB03

ATC

fluoxetine; oral

1.4

18.8

860

6265

C71.82

ICD-10 Finland

Overall malignant tumor of the brain grade III glioma

+∞

18.7

AA5FK

NOMESCO Finland

Functional assessment (fMRI) of brain

+∞

18.7

9531/0-C70.0

ICD-O-3

Meningothelial meningioma of cerebral meninges

15.8

18.7

N05AN01

ATC

lithium; oral

2.1

18.7

176

847

96610

ICD-8 Finland

Adverse effect of anticonvulsants, Hydantoin derivatives

70.0

18.7

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.6

18.7

107

415

5AB01, ,

NOMESCO Finland

6.8

18.6

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

18.6

679

4742

N05BA12

ATC

alprazolam; oral

1.5

18.6

697

4895

C71

ICD-10 Finland

Malignant neoplasm of brain

100.2

18.5

G30.0

ICD-10 Finland

Alzheimer disease with early onset

3.0

18.5

272

E87.8

ICD-10 Finland

Other disorders of electrolyte and fluid balance, not elsewhere classified

5.7

18.5

N06DX01

ATC

memantine; oral

1.5

18.4

577

3909

G30.1

ICD-10 Finland

Alzheimer disease with late onset

1.6

18.2

476

3101

9537/0-C70.0

ICD-O-3

Transitional meningioma of cerebral meninges

21.7

18.1

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

18.0

2899

24969

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

2.7

18.0

342

RS313, ,

NOMESCO Finland

5.0

18.0

N03AA02

ATC

phenobarbital; systemic

15.3

17.9

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.1

17.9

178

875

ZY000

NOMESCO Finland

Hospital inpatient

2.6

17.8

104

407

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.1

17.8

159

750

D42.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Cerebral meninges

16.5

17.8

C71.9

ICD-10 Finland

Malignant neoplasm: Brain, unspecified

16.5

17.8

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.6

17.8

102

396

G93.6

ICD-10 Finland

Cerebral oedema

26.7

17.8

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.7

17.8

855

11444

9401/3-C71.9

ICD-O-3

Astrocytoma, anaplastic, NOS, of brain, NOS

+∞

17.7

9451/3-C71.1

ICD-O-3

Oligodendroglioma, anaplastic, NOS, of frontal lobe

+∞

17.7

ZX120

NOMESCO Finland

Intravenous

1.4

17.7

691

4889

9680/3-C71.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of brain, NOS

20.0

17.7

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.5

17.7

487

3210

N06AX21

ATC

duloxetine; oral

1.4

17.6

844

6194

9400/3-C71.2

ICD-O-3

Astrocytoma, NOS, of temporal lobe

95.2

17.5

P03

ICPC

Feeling depressed

1.4

17.5

743

5337

R2110

NOMESCO Finland

Giving the first information

1.6

17.5

458

2984

C09AA05

ATC

ramipril; oral

1.3

17.5

1879

15467

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.1

17.3

164

791

A46

ICD-10 Finland

Erysipelas

1.3

17.3

1138

8775

J01CA08

ATC

pivmecillinam; oral

1.2

17.2

2797

24090

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.7

17.2

302

1780

R13

ICD-10 Finland

Dysphagia

1.5

17.1

525

3540

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

17.1

327

1972

I67.8

ICD-10 Finland

Other specified cerebrovascular diseases

4.2

17.1

108

Z29

ICPC

Social problem NOS

2.0

17.1

178

890

F79.9

ICD-10 Finland

Unspecified mental retardation, without mention of impairment of behaviour

12.5

17.1

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

4.0

17.0

117

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

17.0

1398

11121

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

3.9

17.0

126

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.0

17.0

177

885

RS121, ,

NOMESCO Finland

3.3

17.0

197

SPAT1153

SPAT

Removal of sutures

1.2

16.8

2341

19831

I63

ICD-10 Finland

Cerebral infarction

2.9

16.8

261

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.6

16.7

446

2918

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

16.7

3021

26287

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.8

16.7

228

1249

3458X

ICD-9 Finland

Epilepsy, Other forms of epilepsy

+∞

16.7

R62.0

ICD-10 Finland

Delayed milestone

3.2

16.6

210

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.8

16.6

243

1361

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.5

16.5

485

3243

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.0

16.5

172

861

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

16.5

480

3203

9380/3-C71.9

ICD-O-3

Glioma, malignant of brain, NOS

27.5

16.5

Z08

ICPC

Social welfare problem

2.4

16.4

110

460

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.1

16.4

149

709

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

2.7

16.3

332

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.2

16.2

140

652

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

2.9

16.2

261

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

2.2

16.1

127

570

3431A

ICD-9 Finland

Infantile cerebral palsy, Hemiplegic

30.0

16.1

AAD00

NOMESCO Finland

Evacuation of epidural haematoma

16.7

16.0

G43.3

ICD-10 Finland

Complicated migraine

2.3

16.0

122

540

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

16.0

558

3865

D33.08

ICD-10 Finland

Another benign tumor of the cerebral ventricle

24.5

16.0

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

16.0

630

4466

RT490, ,

NOMESCO Finland

13.5

15.9

XX1FW

NOMESCO Finland

Written report from MRI examination performed elsewhere

13.5

15.9

H53.1

ICD-10 Finland

Subjective visual disturbances

1.5

15.9

517

3529

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

2.6

15.9

336

XF600

NOMESCO Finland

Bloodpressure measurement

1.5

15.9

495

3349

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

15.9

1391

11150

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

790

1791

4.72

322.83

1.6

28.07

25.22

e6/l

0.13

611

1291

(3019977) pH of Arterial blood

2260

9952

2.66

322.83

8.2

7.9

7.42

0.05

1428

5334

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

795

1813

4.69

322.46

1.7

4242.05

3137.25

e6/l

0.13

649

1397

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6158

41969

2.31

320.42

9.3

7.6

1.20

1.21

mmol/l

34.96

5509

36382

(3027801) Oxygen [Partial pressure] in Arterial blood

2251

9966

2.64

317.47

8.1

7.9

13.96

12.36

kpa

26.07

2167

9566

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2251

9970

2.64

317.18

8.1

7.9

5.04

5.09

kpa

1.46

2168

9573

(3003396) Base excess in Arterial blood by calculation

2234

9890

2.64

314.82

8.2

7.9

1.02

0.88

mmol/l

0.97

1811

8093

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

461

432

11.16

307.65

1.8

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1615

735

26.22

307.65

3.8

6.3

363.30

358.95

umol/l

0.32

1434

630

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2968

13129

2.83

307.65

2.4

2.3

28.80

29.82

14.12

2887

12765

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

844

1810

5.02

307.65

1.5

3.85

3.73

mmol/l

2.16

803

1706

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

261

92.46

307.65

3.4

3.2

42.38

37.45

umol/l

0.41

238

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1149

2964

4.27

307.65

2.4

2.3

362.68

589.07

ug/l

1.78

1104

2816

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

738

101.09

307.65

3.4

2.1

29.80

26.68

umol/l

1.07

560

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

921

2050

4.86

307.65

1.5

542.14

529.42

mg/l

0.25

889

1957

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

1401

321.48

307.65

2.6

2.3

54.38

36.00

umol/l

3.14

1246

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5383

25378

3.56

307.65

3.7

2.2

221.49

215.23

u/l

0.13

5236

23977

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

544

750

7.63

307.65

1.7

1.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

246

122

20.66

307.65

2.3

2.1

19.50

15.21

umol/l

3.43

246

122

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5788

37573

2.36

307.65

8.5

7.1

1.20

1.21

mmol/l

38.13

5536

34812

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

137

73.11

253.90

1.1

1.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

396

605

6.78

247.21

1.4

1.2

2.18

2.07

mmol/l

0.85

368

562

(3013826) Glucose [Moles/volume] in Serum or Plasma

6631

49107

2.14

245.76

8.0

5.2

6.62

6.71

mmol/l

2.78

6438

46466

(3023183) Ammonium ion [Moles/volume] in Plasma

706

1813

4.12

244.10

2.9

31.20

34.03

umol/l

2.14

641

1638

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

313

414

7.78

222.46

1.2

1.1

—

(3032080) INR in Blood by Coagulation assay

5447

38465

1.96

218.23

16.9

15.8

1.25

1.28

inr

4.29

4709

32170

(3016502) Oxygen saturation in Arterial blood

1862

8930

2.35

211.62

8.9

8.2

96.12

95.54

3.55

1804

8609

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

291

375

7.97

211.43

1.2

1.1

—

(3023368) Bacteria identified in Blood by Culture

3761

23722

1.96

207.28

4.9

4.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1754

8282

2.37

206.11

9.2

8.7

123.02

121.33

g/l

2.92

1722

8086

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

280

372

7.72

198.14

1.7

1.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2510

14286

2.02

181.00

4.0

3.8

0.81

0.82

mmol/l

2.00

2362

13481

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4488

31090

1.83

176.32

5.2

3.9

44.10

80.44

ng/l

1.09

3536

21695

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2509

14427

2.00

174.84

2.1

1.9

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

346

661

5.39

171.35

2.0

1.4

0.69

1.31

promille

10.57

287

519

(3018418) pH of Serum or Plasma

3766

24945

1.84

169.18

4.5

4.3

7.40

1.41

2835

17798

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1190

5180

2.48

164.96

8.0

10.2

24.28

24.24

mmol/l

0.21

1173

5063

(3003181) Sodium [Moles/volume] in Urine

540

1512

3.72

164.11

1.5

69.40

63.66

mmol/l

2.08

449

1222

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

83.68

156.50

1.1

1.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1346

6345

2.30

155.31

8.2

9.5

24.42

24.81

mmol/l

4.27

1336

6308

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1174

5219

2.42

154.88

9.7

6.5

24.69

24.45

mmol/l

1.26

1130

4985

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1572

7964

2.16

151.75

2.5

2.3

372.72

376.93

nmol/l

0.34

1449

7396

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1235

5692

2.34

149.86

9.0

10.1

1.35

1.32

0.49

1225

5658

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

200

249

8.18

149.42

1.3

1.1

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1201

5517

2.34

146.67

9.1

10.4

0.69

0.63

5.36

1194

5480

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1937

10755

2.00

145.51

2.0

1.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1538

7987

2.10

138.12

7.5

8.2

1.43

1.33

mmol/l

2.37

1507

7810

(3026008) Bacteria identified in Urine by Culture

3617

24893

1.73

133.90

3.8

3.3

—

(3023410) Appearance of Cerebral spinal fluid

351

854

4.23

129.46

1.7

2.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1798

10104

1.96

128.72

2.1

1.9

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

4979

37595

1.67

128.34

6.0

5.4

34.94

35.65

g/l

14.23

4703

35221

(3033658) Prothrombin time (PT) actual/Normal

3169

21497

1.71

120.54

5.1

4.5

88.61

88.15

0.48

3094

21042

(3000991) Gas panel - Venous blood

1507

8132

2.01

120.49

8.3

9.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5531

43410

1.65

118.36

8.9

6.7

10.14

12.11

umol/l

25.11

5273

41370

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1653

9413

1.91

112.19

4.4

4.5

5.91

5.81

kpa

3.53

1617

9179

(3020891) Body temperature

881

3969

2.34

111.08

5.6

4.5

36.91

°c

0.26

874

3923

(3018405) Lactate [Moles/volume] in Arterial blood

676

2702

2.61

110.42

4.9

3.8

1.50

1.40

mmol/l

1.22

667

2652

(3043409) Potassium [Moles/volume] in Arterial blood

593

2230

2.77

109.24

5.3

4.1

3.87

3.90

mmol/l

0.80

588

2207

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

199

347

5.83

108.58

1.2

1.1

—

0.08

—

(3024354) Oxygen [Partial pressure] in Venous blood

1440

7934

1.96

107.43

4.1

4.64

4.59

kpa

0.27

1405

7719

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

159

223

7.23

107.14

1.2

1.1

—

(3002032) Base excess in Venous blood by calculation

1599

9195

1.89

104.62

4.4

4.6

1.93

1.69

mmol/l

1.99

1425

7988

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

153

215

7.21

102.92

1.2

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

155

221

7.11

102.91

1.2

1.0

—

(3012544) pH of Venous blood

1625

9572

1.84

97.89

4.4

4.6

7.37

7.38

0.61

993

5593

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

910

4394

2.18

96.57

1.6

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

293

776

3.86

96.08

1.1

1.0

—

(3036489) Thrombin time

733

3250

2.36

95.39

2.5

2.7

21.02

21.24

0.40

670

2898

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1882

11719

1.75

93.56

5.8

6.7

1.03

1.06

mmol/l

5.89

1760

10944

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

140

206

6.88

90.30

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

10.30

88.79

1.2

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

3774

28307

1.55

87.68

4.6

3.5

2.34

2.35

mmol/l

11.04

3454

25750

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

11.81

87.52

1.2

1.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

173

336

5.22

83.99

1.2

1.1

555.52

321.36

ng/l

0.22

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

185

381

4.93

83.96

1.6

1.2

51.22

72.00

2.46

(3019309) Folate [Moles/volume] in Red Blood Cells

2133

14173

1.65

81.82

1.9

1.8

1191.67

1155.66

nmol/l

1.10

1689

10753

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

958

5009

2.01

81.69

10.9

10.3

16.26

16.00

2.20

921

4826

(3008295) Osmolality of Serum or Plasma

305

926

3.37

81.43

1.4

1.5

276.94

280.06

mosm/kgh2o

1.22

220

702

(3031040) Bacteria [#/volume] in Urine by Automated count

6374

54008

1.54

80.75

6.1

4.7

3587.72

1900.20

e6/l

0.86

116

756

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1513

9210

1.76

80.12

10.0

7.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

247

665

3.78

79.10

1.2

41.20

41.68

mg/l

0.06

216

555

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

3986

30735

1.51

78.74

4.0

3.6

—

2.10

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

241

641

3.83

78.54

1.1

268.73

264.12

mg/l

0.12

223

566

(3020779) Urea [Moles/volume] in Serum or Plasma

1386

8279

1.79

78.16

6.7

8.0

8.05

9.92

mmol/l

20.94

1322

7942

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

127

197

6.52

77.94

1.1

1.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1209

7044

1.82

73.79

2.7

2.4

5.81

7.55

ug/l

3.72

1044

6157

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

883

4644

1.99

73.74

3.7

3.4

1.30

1.24

0.97

878

4618

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2862

20794

1.54

73.59

2.7

2.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

5728

47992

1.48

72.14

12.6

9.8

4.11

4.15

e9/l

0.63

5024

41433

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

9.72

71.51

1.2

1.1

—

(3026782) Osmolality of Urine

2370

16616

1.57

71.11

3.2

3.1

534.33

537.88

mosm/kgh2o

0.33

2106

14600

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

956

5239

1.92

70.62

1.8

1.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

221

596

3.77

70.61

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

9.71

69.74

1.2

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

983

5465

1.89

69.43

4.7

4.4

1.72

1.68

mmol/l

0.12

730

4020

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

824

4322

1.99

69.18

4.5

4.3

50.30

47.38

2.92

814

4253

(3004119) Hemoglobin [Mass/volume] in Venous blood

974

5472

1.87

66.44

3.9

3.8

129.62

129.36

g/l

0.13

956

5320

(3006315) Basophils [#/volume] in Blood

5219

43317

1.45

66.32

7.6

6.6

0.04

e9/l

12.96

4512

37058

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1088

6335

1.81

66.10

4.8

4.5

5.21

5.12

kpa

2.90

1028

6061

(3001604) Monocytes [#/volume] in Blood

5204

43193

1.45

65.97

7.6

6.6

0.60

0.59

e9/l

0.29

4504

36929

(3019198) Lymphocytes [#/volume] in Blood

5303

44189

1.45

65.68

7.7

6.7

1.82

1.92

e9/l

2.47

4666

38744

(3013115) Eosinophils [#/volume] in Blood

5337

44567

1.45

65.07

8.0

6.8

0.17

0.20

e9/l

14.97

4667

38780

(3009343) pH of Capillary blood

1062

6170

1.81

64.93

4.8

4.5

7.41

7.42

3.24

916

5087

(4035726) Immunohistochemistry procedure

1176

7063

1.76

64.17

1.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7060

62363

1.50

63.13

10.8

8.3

82.40

80.52

u/l

2.01

6762

59275

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

103

161

6.45

62.78

1.1

1.4

—

(1761868) Lipid panel - Serum or Plasma

2275

30689

0.66

61.83

3.2

3.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2275

16242

1.52

61.34

3.3

3.0

2.44

2.45

mmol/l

6.06

2038

14498

(3027273) Bicarbonate [Moles/volume] in Venous blood

738

3895

1.97

60.60

3.8

3.7

25.31

25.17

mmol/l

0.51

714

3761

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

726

3830

1.97

59.66

8.0

4.8

1.69

1.62

1.01

686

3615

(3016038) Potassium [Moles/volume] in Urine

204

586

3.53

59.38

1.4

34.17

35.50

mmol/l

0.35

177

521

(4027681) Cerebrospinal fluid IgG ratio and IgG index

184

493

3.78

59.37

1.2

0.55

0.64

ratio

1.93

110

289

(3007930) Methemoglobin/Hemoglobin.total in Blood

679

3534

1.99

57.97

8.4

5.0

0.91

0.88

1.10

640

3332

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

990

5816

1.78

57.96

4.4

4.9

24.26

24.08

mmol/l

1.12

979

5754

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

264

901

2.98

57.90

1.5

1.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3385

26489

1.43

56.03

3.3

2.7

56.95

63.59

u/l

1.33

3162

24629

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4673

38710

1.40

55.75

3.2

2.9

—

estimate

—

(3002582) Erythrocytes [#/volume] in Urine

3536

28085

1.41

52.98

4.0

3.6

54.62

84.44

e6/l

1.78

2857

21493

(4198724) Urine methamphetamine measurement

151

404

3.78

48.87

1.7

3.1

—

(3000850) Epithelial cells [#/volume] in Urine

2566

19486

1.43

48.53

3.1

2.8

5.87

5.25

e6/l

1.45

2406

17739

(3021960) Folate [Moles/volume] in Serum or Plasma

3042

23807

1.41

48.51

1.9

1.7

18.84

19.91

nmol/l

3.74

2675

20341

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

12.48

46.88

1.0

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

3085

24331

1.39

46.54

3.8

3.5

0.40

0.42

e6/l

0.21

2417

17910

(3039000) Anion gap in Blood by calculation

380

1723

2.25

46.42

11.8

6.5

11.06

11.38

mmol/l

0.98

344

1536

(3018572) Chloride [Moles/volume] in Blood

380

1724

2.25

46.36

11.9

6.5

104.50

105.01

mmol/l

0.91

344

1538

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2201

16364

1.45

46.32

4.7

4.0

220.66

491.16

ng/l

3.56

1723

12825

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3456

27873

1.37

45.14

4.4

3.4

32.50

34.22

u/l

0.59

3265

26300

(3028707) Methadone [Presence] in Urine by Screen method

354

1577

2.29

45.10

2.9

3.0

—

(3028271) Lactate [Moles/volume] in Capillary blood

311

1315

2.41

44.65

2.3

1.9

2.23

1.68

mmol/l

7.83

304

1285

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

225

813

2.81

44.51

1.6

1.8

—

(3047181) Lactate [Moles/volume] in Blood

496

2533

2.01

44.48

10.5

5.5

1.46

1.32

mmol/l

1.39

441

2228

(3019069) Monocytes/Leukocytes in Blood

4703

39911

1.35

43.78

7.9

6.9

9.16

8.88

8.19

4451

37448

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

986

6225

1.65

43.76

1.9

1.7

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

561

3014

1.91

43.38

2.0

1.8

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1457

10100

1.52

43.22

2.3

1.8

1.71

1.46

19.22

1298

8842

(3006504) Eosinophils/Leukocytes in Blood

4686

39819

1.35

42.87

7.8

6.9

2.60

2.88

13.42

4439

37352

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

108

249

4.37

42.81

1.4

1.2

23.52

26.32

0.14

(3029937) Albumin [Presence] in Urine by Test strip

3044

24212

1.38

42.72

5.1

4.1

0.00

estimate

3.22

945

8373

(3022096) Basophils/Leukocytes in Blood

4680

39798

1.34

42.41

7.9

6.9

0.64

0.67

5.49

4433

37314

(3019150) Specific gravity of Urine by Refractometry

2534

19616

1.40

41.71

5.2

4.1

1.02

1.17

kg/l

0.80

1716

13100

(3012501) Base excess in Blood by calculation

369

1744

2.16

40.68

4.3

4.4

2.33

2.49

mmol/l

0.60

261

1157

(3013290) Carbon dioxide [Partial pressure] in Blood

369

1745

2.16

40.62

4.3

4.4

5.05

4.98

kpa

1.17

360

1707

(3027315) Oxygen [Partial pressure] in Blood

370

1754

2.15

40.48

4.3

4.4

8.65

8.67

kpa

0.08

361

1715

(3015736) pH of Urine

4228

35577

1.34

40.39

4.2

3.5

6.47

6.22

34.26

2272

19777

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

498

2644

1.93

39.87

1.3

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

6.67

39.80

1.5

1.1

48.83

57.28

0.51

(3002030) Lymphocytes/Leukocytes in Blood

4766

40881

1.33

39.55

7.8

6.9

26.47

27.85

13.78

4561

38751

(3018095) Leukocytes [#/volume] in Urine

3832

31858

1.34

39.43

4.8

4.2

97.60

92.98

e6/l

0.08

2912

22561

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

163

527

3.13

39.35

1.0

367.57

312.19

ng/l

0.34

126

370

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

534

2917

1.88

39.19

3.5

3.8

0.36

0.34

iu/ml

0.66

343

1593

(36304419) Bacteria [Presence] in Urine

2906

23195

1.36

39.07

3.8

3.4

1.66

142.44

estimate

0.62

109

(3018010) Neutrophils/Leukocytes in Blood

4680

40101

1.33

38.83

7.7

6.7

58.02

57.17

4.87

4501

38320

(1616796) Gas panel - Central venous blood

396

1962

2.06

38.57

3.9

4.0

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

557

3104

1.84

38.37

3.3

3.2

24.67

24.68

mmol/l

0.02

549

3049

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.81

38.06

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

502

2723

1.89

37.64

3.2

3.3

3.40

3.52

g/l

1.04

481

2606

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

161

531

3.07

37.59

1.0

38.03

41.54

ng/l

0.60

122

370

(3028626) Oxygen [Partial pressure] in Capillary blood

519

2851

1.87

37.41

5.3

4.8

8.69

8.58

kpa

0.66

506

2785

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2863

22943

1.35

37.06

2.4

2.81

2.80

mg/l

0.07

2446

19912

(40767503) Oxygen content in Capillary blood by calculation

367

1795

2.09

37.01

2.9

2.7

16.88

16.44

1.96

357

1762

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

159

528

3.04

36.69

1.0

707.94

743.98

ng/l

0.42

120

359

(3035350) Ketones [Presence] in Urine by Test strip

5087

44358

1.31

36.05

4.8

3.9

4.44

3.97

estimate

0.07

1058

9344

(3011397) Hemoglobin [Presence] in Urine by Test strip

2582

20438

1.36

35.98

4.6

3.8

0.28

0.39

0.15

215

(3019225) pH of Specimen

1124

7655

1.53

35.71

4.6

4.4

7.36

7.35

0.82

957

5494

(3037467) Urinalysis macro (dipstick) panel - Urine

6272

56346

1.33

35.64

5.6

4.6

2.67

2.46

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

140

439

3.22

35.60

1.1

1.11

1.14

u/l

0.19

183

(3010421) pH of Blood

488

2682

1.86

35.10

4.1

4.0

7.41

0.41

479

2648

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

599

3522

1.75

34.40

2.4

1.9

2.72

2.27

ug/l

0.32

505

3120

(3009261) Glucose [Presence] in Urine by Test strip

5093

44619

1.30

33.89

4.8

4.0

2.01

0.16

estimate

0.72

1000

8817

(3021601) Nitrite [Presence] in Urine by Test strip

5015

43851

1.30

33.84

4.8

3.9

0.00

estimate

1.60

1019

9152

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6094

54901

1.30

31.74

4.8

3.4

65.99

47.13

u/l

23.79

5829

51657

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

532

8744

0.59

31.22

1.9

3.52

3.53

ratio

0.04

396

6679

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

603

3653

1.69

31.03

5.6

4.9

24.80

24.67

mmol/l

0.48

562

3388

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1397

10209

1.43

30.75

4.6

4.5

251.87

242.80

u/l

0.64

1316

9685

(3045716) Anion gap in Serum or Plasma by calculation

211

892

2.40

30.39

3.0

3.2

11.03

10.63

mmol/l

0.58

211

877

(3007853) Bacteria identified in Skin by Aerobe culture

1393

10224

1.42

29.86

1.9

1.8

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.71

29.33

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

104

5.41

28.72

1.1

1.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

548

3306

1.70

28.61

2.1

2.0

—

(3021901) Oxygen saturation in Capillary blood

353

1872

1.92

28.34

3.0

3.2

90.47

89.87

0.80

343

1827

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

120

394

3.07

28.33

2.5

2.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

450

2578

1.78

28.23

3.6

3.2

188.67

191.33

0.26

427

2465

(3022806) Fractional oxyhemoglobin in Capillary blood

220

980

2.27

28.12

2.2

1.9

89.25

89.69

0.57

213

968

(3022313) Gas panel - Capillary blood

693

4461

1.60

27.98

5.2

4.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

130

453

2.89

27.65

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

119

395

3.04

27.59

2.2

137.10

143.51

umol/l

0.08

210

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7237

76885

0.76

27.57

5.0

4.9

1.45

1.43

mmol/l

2.95

6751

71685

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

371

6493

0.55

27.29

1.6

1.7

3.48

3.47

mmol/l

0.06

243

4431

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1944

15289

1.34

26.95

3.4

3.1

1.16

1.30

e6/l

0.27

1078

8213

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

107

5.16

26.82

1.1

1.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

251

1206

2.11

26.59

5.8

6.7

10.85

11.79

mg/l

2.38

223

1122

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4212

36722

1.26

26.23

2.3

2.1

94.35

95.47

pmol/l

0.81

2403

19828

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2266

18303

1.31

25.88

2.1

1.9

1.22

1.27

mg/l

0.28

1782

14158

(3019550) Sodium [Moles/volume] in Serum or Plasma

8444

80466

1.41

25.43

31.6

19.3

138.44

139.67

mmol/l

208.81

8337

78872

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7435

78495

0.76

24.99

5.7

2.61

2.68

mmol/l

10.11

6954

73330

(3027945) Reticulocytes/Erythrocytes in Blood

1381

10408

1.38

24.98

3.0

2.8

1.82

1.75

1.66

1221

9297

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2971

24949

1.28

24.95

3.3

3.4

1435.74

1515.37

ng/l

0.41

2596

21571

(3024869) Neuronal Ab [Presence] in Serum

134

4.50

24.89

1.1

—

(40758558) Short blood count panel - Blood

3005

25277

1.27

24.87

8.4

6.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

469

2818

1.70

24.84

2.9

3.2

95.81

92.36

2.29

450

2726

(3014271) Vancomycin [Susceptibility]

111

377

2.97

24.76

2.9

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7319

77348

0.77

23.99

5.1

5.0

4.52

4.57

mmol/l

4.15

6860

72553

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

8.40

23.97

1.8

1.2

29.63

38.57

0.42

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

19.50

23.38

1.1

1.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

942

6717

1.45

23.30

2.6

2.9

10.10

10.51

g/l

1.79

867

6205

(3042936) Bacteria identified in Isolate by Culture

1570

12193

1.34

23.29

2.3

2.0

—

(3023520) Reticulocytes [#/volume] in Blood

1093

8019

1.41

23.07

2.9

2.7

70.17

68.92

e9/l

0.49

790

5823

(44816559) Phosphatidylethanol [Mass/volume] in Blood

565

3628

1.59

23.00

2.0

1.7

0.31

mg/l

0.05

305

1719

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2123

17229

1.30

22.97

1.7

29623841.53

31071484.19

pmol/l

0.04

1779

14425

(3052851) Hemolysis interference index of Serum or Plasma

401

2364

1.73

22.77

3.7

3.3

2.49

2.09

index

0.37

235

1233

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1770

14042

1.32

22.59

3.6

3.3

3.36

2.31

e6/l

3.01

900

6947

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.56

22.51

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1127

8373

1.39

22.05

2.5

0.21

g/l

0.59

1040

7817

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

758

5252

1.48

21.72

1.3

44.76

54.55

au/ml

0.55

339

(21494755) Public health laboratory ask at order entry panel

475

7380

0.62

21.70

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

318

1780

1.81

21.60

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

318

1780

1.81

21.60

1.4

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

809

5690

1.46

21.46

2.4

26.49

20.44

au/ml

0.94

614

(3023103) Potassium [Moles/volume] in Serum or Plasma

8427

80646

1.37

21.43

31.0

19.5

3.97

3.98

mmol/l

1.02

8305

78914

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

170

768

2.23

21.12

2.6

3.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3772

33056

1.23

20.64

4.9

3.9

0.84

0.26

estimate

0.47

859

7570

(3024928) Oxygen saturation in Venous blood

383

2307

1.69

20.12

3.8

3.9

62.86

62.04

0.29

366

2237

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

5.82

20.04

1.2

1.1

11.83

20.06

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

465

2948

1.61

19.96

2.7

2.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

5.98

19.45

1.3

1.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

979

7273

1.38

19.02

2.3

2.6

65.69

66.24

g/l

1.25

885

6668

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2880

33214

0.81

18.95

1.9

1.37

1.36

mmol/l

0.23

2489

28128

(3040151) Glucose [Moles/volume] in Capillary blood

202

1021

2.00

18.77

8.8

6.4

7.25

7.31

mmol/l

0.09

174

858

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

313

2.86

18.75

1.1

—

(3016879) Cocaine [Presence] in Urine

527

3495

1.54

18.60

2.6

2.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

123

4.08

18.39

1.1

2.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

101

4.37

17.71

1.7

1.8

—

(44790047) Parainfluenza type 1 nucleic acid detection

217

1151

1.91

17.54

1.5

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

217

1151

1.91

17.54

1.5

1.6

—

(44790048) Parainfluenza type 2 nucleic acid detection

217

1151

1.91

17.54

1.5

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

217

1151

1.91

17.54

1.5

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

107

431

2.50

17.31

2.3

2.6

44.99

54.22

umol/l

0.15

(3011288) Drugs identified in Urine by Screen method Nominal

406

2586

1.59

17.12

3.5

3.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

391

2476

1.60

16.90

1.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8303

79760

1.31

16.77

26.1

16.5

24.87

24.99

mg/l

0.13

7449

65861

(3000764) Benzodiazepines [Presence] in Urine

545

3733

1.49

16.50

2.5

2.2

—

(3027008) Opiates [Presence] in Urine

547

3750

1.49

16.48

2.5

2.0

—

(3028300) Cannabinoids [Presence] in Urine

547

3757

1.48

16.33

2.6

2.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

370

2334

1.61

16.26

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

181

3.27

15.77

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

356

2257

1.60

15.34

1.6

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

924

7037

1.35

15.22

2.8

2.6

0.46

0.44

e6/l

0.11

892

6765

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6613

62159

1.21

15.14

4.8

4.3

14.42

14.79

pmol/l

26.37

6118

57121

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

578

4078

1.44

15.02

1.9

1.7

1.51

1.52

g/l

0.10

468

3532

(3006184) Hemoglobin [Mass/volume] in Capillary blood

339

2138

1.61

14.93

2.4

2.3

132.07

129.73

g/l

1.06

289

1657

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

229

1301

1.78

14.92

1.4

1.3

4.78

4.24

u/ml

0.23

112

610

(3021589) Normoblasts [#/volume] in Blood

4137

37360

1.19

14.75

14.1

11.8

0.00

e9/l

0.51

3344

30249

(3017569) Oxygen content in Arterial blood

108

473

2.30

14.59

1.9

2.2

15.72

16.10

0.55

108

473

(3027944) Amphetamines [Presence] in Urine

529

3695

1.46

14.50

2.3

2.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

127

3.63

14.48

1.0

1.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1704

14145

1.25

14.41

2.7

2.28

2.32

g/l

1.77

1565

13076

(3022948) Iron [Moles/volume] in Serum or Plasma

1811

15139

1.24

14.37

2.7

12.66

12.97

umol/l

0.92

1662

14118

(3019230) Fractional oxyhemoglobin in Venous blood

313

1961

1.62

14.19

3.8

62.32

62.48

0.04

313

1955

(3044242) Glucose [Moles/volume] in Arterial blood

104

461

2.27

13.68

2.2

2.0

7.75

7.94

mmol/l

0.17

104

461

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

314

1988

1.60

13.64

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

860

6585

1.34

13.62

4.2

4.1

1.22

1.23

mmol/l

6.43

799

5685

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7002

73298

0.83

13.39

4.4

4.2

1.29

mmol/l

0.00

6493

67698

(4034850) Laboratory test

368

2431

1.53

13.28

12.3

10.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1052

8319

1.30

13.20

4.3

3.5

—

(3011985) Renin [Units/volume] in Plasma

209

1204

1.75

13.04

1.7

1.5

59.29

70.71

mu/l

0.38

194

1075

(3011412) CD3 cells [#/volume] in Blood

163

876

1.87

12.78

2.3

2.7

1125.40

1198.92

e6/l

0.43

141

746

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

101

456

2.23

12.75

1.2

1.1

1620.64

1521.25

miu/ml

0.36

101

456

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1403

16884

0.80

12.68

2.9

3.2

0.76

0.78

ug/l

0.19

974

11065

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

309

2.50

12.68

2.9

2.5

135.76

144.52

nmol/l

0.40

270

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

221

1320

1.69

12.13

1.4

1.3

6.32

3.43

u/ml

1.03

474

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

282

1794

1.59

12.05

1.7

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

308

2000

1.56

12.05

1.5

1.7

—

(3008037) Lactate [Moles/volume] in Venous blood

316

2070

1.54

11.89

4.0

3.3

1.70

1.59

mmol/l

0.67

309

2011

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

136

3.24

11.71

2.2

2.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

158

866

1.84

11.69

3.3

4.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

453

2.15

11.32

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

199

1179

1.70

11.29

1.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1553

13073

1.22

11.26

2.8

22.53

22.42

0.09

1428

12155

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

193

1135

1.71

11.25

1.3

1.4

278.99

343.28

pmol/l

1.24

167

957

(3004809) Band form neutrophils/Leukocytes in Blood

233

1442

1.63

11.19

3.1

3.7

1.44

1.57

0.21

214

1279

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

4.09

10.84

1.1

1.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

661

5038

1.33

10.79

2.9

3.4

4.29

4.51

pmol/l

6.78

600

4501

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

418

2958

1.43

10.75

2.5

2.6

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.96

10.72

1.1

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

144

3.06

10.69

2.2

2.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

104

3.47

10.67

1.9

4.0

—

(3028433) Virus identified in Specimen by Culture

282

2.42

10.51

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

122

640

1.92

10.39

2.4

2.8

500.91

507.81

e6/l

0.05

502

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

168

2801

0.59

10.30

1.1

0.62

0.64

ratio

0.12

341

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7104

73854

0.85

10.26

6.5

6.4

38.95

39.26

mmol/mol

1.94

6652

69290

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

149

837

1.79

10.23

2.9

3.1

20.13

20.33

nmol/l

0.08

135

805

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1005

8179

1.26

9.90

2.7

2.6

40.45

44.57

u/l

0.21

843

6911

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

332

2288

1.47

9.85

1.2

2.94

4.11

1.44

281

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

122

653

1.88

9.80

2.4

3.0

212.05

220.71

e6/l

0.18

100

537

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

181

1090

1.67

9.73

1.4

24.06

25.73

u/l

0.30

150

908

(3042517) Benzodiazepines panel - Urine

3.49

9.58

3.3

2.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1204

10048

1.23

9.39

3.1

7.09

8.39

umol/l

2.07

1007

8802

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

267

2.37

9.33

1.4

1.5

13.26

15.45

pmol/l

1.84

224

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

13.65

9.16

1.3

1.0

—

(3017181) Myelocytes/Leukocytes in Blood

939

7665

1.25

8.99

4.4

4.6

1.19

0.95

1.94

383

2334

(40757373) Influenza virus identified in Isolate

154

2.80

8.97

1.6

1.5

—

(3045414) Leukocytes [Presence] in Urine

979

8033

1.24

8.95

2.2

2.1

0.01

estimate

0.09

163

1650

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

124

691

1.80

8.81

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

124

691

1.80

8.81

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

124

691

1.80

8.81

1.5

1.7

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

404

2.06

8.80

4.1

2.0

161.68

149.95

0.57

388

(4268621) Lupus anticoagulant assay

158

946

1.68

8.73

2.5

2.3

—

(3017354) Segmented neutrophils/Leukocytes in Blood

154

918

1.69

8.65

2.8

3.8

60.79

56.86

1.51

134

787

(3021387) Prolactin [Units/volume] in Serum or Plasma

411

3015

1.38

8.64

1.8

1.7

356.46

291.60

mu/l

3.08

373

2750

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

497

1.94

8.58

2.7

2.6

42.38

39.40

0.82

269

(3037121) Protein [Mass/volume] in Urine

410

3011

1.38

8.57

3.9

3.7

277.53

396.67

mg/l

1.83

234

1451

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

6319

60217

1.14

8.56

4.6

4.4

12.59

11.94

mm/h

2.58

5968

56390

(3001019) Free T4 and TSH panel - Serum or Plasma

256

3727

0.68

8.54

1.7

1.6

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

16.27

8.54

1.2

1.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

234

1548

1.52

8.54

1.8

—

(3002179) Metamyelocytes/Leukocytes in Blood

896

7319

1.25

8.52

4.2

4.4

0.86

0.72

1.22

365

2235

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

361

2603

1.40

8.42

2.3

1.7

0.23

g/l

0.28

347

2479

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4045

37474

1.14

8.42

2.6

2.5

74.12

76.66

nmol/l

6.66

3649

34091

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

124

701

1.78

8.42

2.4

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

453

1.97

8.37

13.0

13.9

0.60

0.62

mmol/l

0.35

417

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

190

1205

1.59

8.37

1.1

117.30

114.79

0.46

168

1093

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

370

2683

1.39

8.35

2.3

1.7

1.19

1.18

g/l

0.17

355

2561

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.87

8.34

2.4

4.8

—

(1175426) CD3 cells/Lymphocytes in Blood

128

734

1.75

8.29

2.2

2.4

75.15

71.09

2.64

123

701

(3051611) Lipemic interference index of Serum or Plasma

139

817

1.71

8.25

3.2

3.6

13.72

13.52

index

0.07

103

478

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

103

3.11

8.07

1.5

1.4

—

(3049233) Organic acids panel - Urine

6.79

8.04

1.4

1.1

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

8.43

7.79

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2114

18823

1.16

7.73

5.7

4.8

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

814

6651

1.24

7.72

3.4

2.7

70.05

66.69

ml/min/173m2

1.31

359

2820

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

225

1510

1.50

7.71

3.1

3.9

603.20

1442.79

u/ml

0.73

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

101

553

1.83

7.66

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

260

2.24

7.63

5.2

3.1

5.00

4.83

kpa

0.43

260

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

261

2.23

7.56

5.1

3.1

10.09

10.50

kpa

0.63

261

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

159

993

1.61

7.51

1.3

0.18

0.20

nmol/l

0.64

125

794

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

182

1180

1.55

7.34

1.3

0.21

0.26

nmol/l

0.30

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

542

1.82

7.22

1.4

—

(3045424) Erythrocytes [Presence] in Urine

523

4086

1.30

7.21

2.3

2.1

0.01

0.21

estimate

0.52

139

1256

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

336

2468

1.37

7.08

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

137

838

1.64

7.06

1.1

—

(4195642) Thrombophilia screening test

183

1200

1.53

7.03

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

251

3527

0.70

6.95

1.5

1.6

1179.79

997.58

mu/l

0.69

207

2991

(3023419) Bacteria identified in Sputum by Culture

165

1067

1.56

6.77

2.5

2.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

191

1280

1.50

6.65

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

435

1.87

6.59

1.3

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

237

1662

1.44

6.56

1.5

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

175

1156

1.52

6.53

1.7

1.6

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

147

934

1.58

6.52

1.2

1.1

92.23

97.02

1.36

133

878

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

103

597

1.73

6.52

1.1

1.2

—

(3013512) EKG study

2997

27572

1.13

6.50

4.3

3.7

0.91

0.75

0.83

(3052592) Norovirus Ag [Presence] in Stool

152

2.51

6.48

1.8

1.3

—

(3021440) Promyelocytes/Leukocytes in Blood

874

7333

1.21

6.43

4.6

4.7

0.14

0.12

0.48

321

2013

(3002079) Sodium [Moles/time] in 24 hour Urine

377

1.92

6.34

1.2

1.3

159.81

167.08

mmol/24h

0.26

377

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

551

1.75

6.31

2.8

3.3

93.65

98.35

0.64

526

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

179

2.35

6.27

1.0

1.2

65.50

77.87

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

179

2.35

6.27

1.1

1.2

75.29

69.61

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

264

1908

1.39

6.19

5.5

6.3

312.03

1875.78

iu/ml

1.03

284

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

399

3077

1.31

6.11

2.5

2.4

7612.18

5692.25

u/l

0.42

114

1194

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

193

1322

1.47

6.07

1.4

—

(3037756) Immunofixation for Serum or Plasma

248

1780

1.40

6.06

1.4

1.6

—

(3006245) CD3-CD19+ cells/cells in Blood

426

1.84

6.06

2.5

2.9

9.29

12.23

1.07

404

(3028026) IgM [Mass/volume] in Serum or Plasma

644

5272

1.24

6.04

1.8

2.0

1.22

1.31

g/l

0.61

583

4856

(3009445) Proteinase 3 Ab [Units/volume] in Serum

467

3685

1.28

6.01

1.6

18.79

16.43

iu/ml

0.11

103

(3009214) Lutropin [Units/volume] in Serum or Plasma

363

2777

1.32

5.91

1.6

1.5

10.71

9.04

u/l

1.32

286

2151

(3017509) Phencyclidine [Presence] in Urine

3.04

5.90

1.5

1.6

—

(3028717) Thiamine [Mass/volume] in Blood

118

2.63

5.87

1.1

1.3

63.45

64.48

ug/l

0.08

118

(3035285) Chloride [Moles/volume] in Venous blood

144

939

1.54

5.76

3.4

2.3

104.33

105.58

mmol/l

1.98

144

928

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

265

2.04

5.75

1.1

83.31

88.43

0.34

134

(3041354) Potassium [Moles/volume] in Venous blood

144

941

1.54

5.71

3.4

2.3

4.05

4.07

mmol/l

0.39

144

930

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

404

3153

1.29

5.69

1.3

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

409

1.81

5.57

2.5

2.6

29.13

27.99

0.31

392

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

234

1691

1.39

5.53

1.4

—

(40768800) Prostate Pathology biopsy report

117

1816

0.64

5.49

1.1

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

140

919

1.53

5.46

3.5

2.4

1.20

mmol/l

0.16

140

908

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

272

1.99

5.38

1.2

1.3

96.02

100.86

0.48

252

(3039443) Prostate specific Ag panel - Serum or Plasma

1464

0.60

5.37

1.5

1.6

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

3.54

5.31

1.1

1.54

5.20

u/l

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

261

2.00

5.24

1.1

1.2

76.00

87.49

0.84

135

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

583

1.65

5.21

1.5

—

(3012787) Ethosuximide [Moles/volume] in Serum or Plasma

+∞

5.21

2.8

0.0

288.00

—

umol/l

—

(3025159) Blasts/Leukocytes in Blood

868

7429

1.18

5.16

4.8

0.22

0.33

0.28

299

1937

(3044889) 12 lead EKG panel

5790

55599

1.10

5.15

4.5

4.1

0.50

3968.76

0.73

109

(3023511) Choriogonadotropin [Units/volume] in Urine

200

1432

1.40

5.03

1.5

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

386

1.79

5.03

1.1

4.20

4.00

iu/ml

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

796

6783

1.19

4.98

3.1

169.08

212.54

ng/l

3.25

731

6183

(3014765) Yersinia sp identified in Stool by Organism specific culture

288

2201

1.32

4.80

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

771

6576

1.19

4.78

4.1

4.3

82.57

90.73

ng/l

1.82

667

5723

(3000494) Fungus identified in Specimen by Culture

1151

10137

1.15

4.76

1.6

1.5

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.27

4.73

4.1

3.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

314

1.85

4.72

4.5

2.0

179.07

171.79

0.23

300

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

137

1990

0.68

4.69

1.4

1.5

51.61

60.37

ug/l

1.70

109

1669

(42529406) Shigella sp [Presence] in Stool by Culture

288

2212

1.31

4.64

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

285

2189

1.31

4.59

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.38

4.42

2.1

4.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2092

22694

0.90

4.35

4.2

4.5

21.64

22.16

0.79

1040

11158

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

183

2.08

4.34

2.9

2.3

1.61

1.71

mmol/l

0.06

129

(3050129) First trimester maternal screen panel - Serum or Plasma

168

2314

0.72

4.28

1.6

1.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

310

2437

1.28

4.22

1.4

1.5

10.50

13.12

iu/ml

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

284

1.83

4.16

1.5

1.4

130.94

302.68

nmol/24h

0.86

284

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

129

1849

0.69

4.16

1.4

1.5

0.99

0.94

ratio

0.62

1105

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

129

1847

0.69

4.13

1.4

1.5

1.05

1.16

ratio

0.68

1103

(3000060) B lymphocytes [#/volume] in Blood

336

1.76

4.12

2.4

2.9

0.89

0.52

e9/l

0.20

176

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

127

1822

0.69

4.12

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

382

1.71

4.07

1.4

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

382

1.71

4.07

1.4

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

130

1849

0.70

4.03

1.4

1.5

1.12

1.22

ratio

0.68

1112

(3047352) Trisomy 18 risk [Likelihood] in Fetus

103

1528

0.67

4.00

1.4

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

136

952

1.43

3.97

1.6

1.7

373.92

346.47

mu/l

0.41

110

758

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

407

3332

1.23

3.93

2.1

2.3

2.93

2.92

g/l

0.05

358

3034

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

417

1.66

3.92

1.4

1.6

2.88

6.64

nmol/l

1.35

329

(3043238) Trisomy 21 risk [Likelihood] in Fetus

107

1566

0.68

3.89

1.5

1.6

—

(3005033) Fetal Nuchal fold Thickness US

102

1500

0.68

3.81

1.4

1.5

1.35

1.25

1.21

1079

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

324

2602

1.25

3.74

2.6

3.2

5.50

3.44

ratio

0.33

212

1512

(3022493) Free Hemoglobin [Mass/volume] in Plasma

400

1.65

3.72

5.7

4.9

73.18

650.98

mg/l

0.49

286

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

181

1.99

3.71

1.1

1.2

359.04

290.90

pmol/l

0.43

127

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

245

1.84

3.68

1.4

120.63

134.34

nmol/l

0.23

181

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

428

3548

1.22

3.68

2.0

2.3

4.13

4.20

g/l

1.02

379

3251

(3033923) Metanephrine [Moles/time] in 24 hour Urine

148

2.10

3.67

1.2

1.1

0.80

0.69

umol/24h

0.48

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

428

3551

1.21

3.65

2.0

2.3

7.22

7.40

g/l

1.42

379

3248

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

145

1044

1.39

3.65

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7529

73665

1.10

3.65

6.0

5.2

1.83

1.92

mu/l

7.16

7049

68322

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2661

28329

0.92

3.64

4.9

5.5

3.38

3.04

ug/l

0.30

2370

25686

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1241

13722

0.89

3.60

1.3

18.32

10.72

u/ml

0.78

488

5307

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

426

3541

1.21

3.57

2.0

2.3

3.58

3.74

g/l

1.29

378

3244

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

644

1.50

3.53

1.4

1.5

13.04

12.95

u/l

0.05

619

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

353

1.67

3.52

3.4

3.5

1.10

1.32

0.54

353

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

147

1069

1.38

3.50

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

222

2842

0.78

3.46

1.6

1.7

6.81

4.44

mg/l

1.04

180

2081

(4094501) Cardiovascular stress test using bicycle ergometer

166

2210

0.75

3.46

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

371

1.65

3.43

1.1

30.17

13.64

u/ml

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

144

1048

1.38

3.42

1.4

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

153

2.03

3.39

1.3

0.83

139.36

mg/l

1.69

114

(3000963) Hemoglobin [Mass/volume] in Blood

8570

86730

0.88

3.36

38.9

24.9

132.31

135.41

g/l

71.11

8498

85827

(3001964) Herpes simplex virus Ag [Presence] in Specimen

231

1.82

3.36

1.5

1.6

—

(3003694) ABO and Rh group [Type] in Blood

2562

24041

1.09

3.34

1.4

1.5

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

531

1.53

3.34

2.2

1.7

15.37

21.96

umol/l

2.59

497

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

5.72

3.33

1.0

1.1

2.85

1.17

mg/l

—

(3026361) Erythrocytes [#/volume] in Blood

8569

86715

0.88

3.33

38.5

24.7

4.37

4.50

e12/l

100.91

8419

84637

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

121

2.15

3.30

1.0

1.3

39.91

112.59

ng/l

1.47

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

136

987

1.38

3.30

1.9

2.1

39.46

23.61

mg/l

1.71

351

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

8569

86711

0.88

3.30

39.4

25.3

39.46

40.84

16.77

8487

85743

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

203

1565

1.30

3.30

1.3

351.43

342.63

titre

0.02

116

(3017732) Neutrophils [#/volume] in Blood

1173

10596

1.12

3.29

3.8

3.2

4.24

4.59

e9/l

1.55

1005

9169

(3024731) MCV [Entitic mean volume] in Red Blood Cells

8569

86707

0.88

3.28

38.5

24.7

91.22

90.87

9.57

8489

85785

(3006922) Hepatitis E virus Ab [Presence] in Serum

655

1.47

3.28

1.1

—

(3035941) MCH [Entitic mass]

8569

86705

0.89

3.27

38.4

24.7

30.51

30.28

27.11

8488

85785

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

352

2902

1.22

3.24

2.7

3.3

41.83

51.78

mg/l

0.45

308

2473

(21494814) CD8 cells/Lymphocytes in Specimen

331

1.66

3.24

1.9

2.2

32.85

31.10

0.39

331

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

3.34

3.21

1.0

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

352

2905

1.22

3.21

2.7

3.3

49.94

74.34

mg/l

0.67

308

2478

(3010813) Leukocytes [#/volume] in Blood

8573

86729

0.89

3.19

38.6

24.8

6.84

6.79

e9/l

0.97

8424

84630

(3033086) Enterovirus Ab [Titer] in Serum

4.17

3.19

1.1

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

199

1.86

3.18

1.4

—

(3007461) Platelets [#/volume] in Blood

8569

86687

0.89

3.17

38.6

24.8

247.75

249.76

e9/l

1.99

8435

84867

(3003129) Base excess in Capillary blood by calculation

138

1013

1.37

3.15

2.4

2.3

1.46

0.42

mmol/l

3.05

130

965

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

428

1.57

3.12

1.6

1.5

3043117.80

1400505.87

iu/ml

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

158

1187

1.34

3.11

1.8

1.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

137

1008

1.36

3.09

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

142

1051

1.36

3.08

1.4

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.33

3.07

1.6

1.3

1.18

1.46

iu/ml

0.51

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

526

1.51

3.06

1.9

2.9

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

667

1.44

3.01

1.2

1.3

11.63

12.68

u/l

0.43

609

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

137

1014

1.36

2.98

1.4

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

425

1.56

2.98

1.1

1.2

331.37

328.56

u/l

0.01

390

(3023420) DNA double strand Ab [Units/volume] in Serum

410

3460

1.19

2.98

2.2

1.8

6.68

6.95

iu/ml

0.08

108

825

(3003434) Protein [Mass/volume] in Pleural fluid

164

1248

1.32

2.97

1.4

1.5

33.63

31.94

g/l

1.00

156

1130

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

348

1.61

2.94

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

137

1017

1.35

2.94

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1449

15718

0.91

2.92

1.7

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

296

1.66

2.88

1.9

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

296

1.66

2.88

1.9

2.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

178

1377

1.30

2.87

1.1

1.2

0.39

1.12

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

115

2.09

2.87

1.2

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

286

2341

1.23

2.87

1.2

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

145

1091

1.33

2.85

1.4

1.5

2341.92

3203.02

e6/l

0.45

115

758

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.29

2.83

3.3

2.4

0.63

0.55

u/field

0.13

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

298

1.65

2.81

2.0

2.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

306

1.64

2.80

1.0

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

392

1.56

2.80

2.2

1.8

1.50

3.15

u/field

1.55

274

(3015171) Extractable nuclear Ab [Units/volume] in Serum

380

3206

1.19

2.79

1.3

1.2

0.53

0.93

u/ml

0.81

272

(3007566) Smooth muscle Ab [Titer] in Serum

296

2439

1.22

2.79

1.3

105.00

144.57

titre

0.38

221

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

115

838

1.38

2.79

1.2

—

32.06

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

365

3072

1.20

2.76

2.0

2.3

0.73

0.87

g/l

0.32

305

2642

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

410

1.54

2.75

1.7

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

410

1.54

2.75

1.8

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

410

1.54

2.75

1.8

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

410

1.54

2.75

1.8

1.9

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

416

3545

1.18

2.73

1.8

1.9

38.85

39.68

u/l

0.32

374

3150

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

293

1.64

2.73

3.1

2.6

0.61

mmol/l

0.04

293

(3028308) Erythrocytes [#/volume] in Pleural fluid

129

961

1.35

2.73

1.4

1.5

69786.87

55777.23

e6/l

0.24

535

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

264

2158

1.23

2.70

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

363

3062

1.19

2.69

2.1

2.3

10.09

10.22

g/l

0.19

311

2734

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

120

887

1.36

2.68

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

134

1010

1.33

2.64

1.1

—

(3008898) HLA-B27 [Presence]

231

2840

0.81

2.63

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

289

1.63

2.61

1.2

926.67

998.25

titre

0.13

(3008536) Aspergillus sp Ab [Presence] in Serum

177

1.81

2.58

2.6

2.3

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

337

1.58

2.58

1.4

2.0

327.40

41433.77

u/ml

—

(3034770) Mitochondria Ab [Titer] in Serum

291

2417

1.21

2.56

1.3

656.00

972.58

titre

—

(3022145) Colonoscopy Study observation

856

9472

0.89

2.54

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1375

14839

0.91

2.48

1.3

29.53

31.08

iu/ml

0.15

370

4376

(3032641) Amino acids panel - Urine

3.81

2.46

1.1

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1103

10097

1.10

2.45

1.7

1.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

109

2.02

2.45

1.2

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7397

75173

0.93

2.43

5.3

5.1

5.89

5.94

mmol/l

2.20

6834

69266

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1168

0.72

2.43

1.1

2.75

3.54

eliau/ml

0.49

517

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

299

2505

1.20

2.42

2.0

2.3

0.01

0.00

g/l

0.45

250

2206

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

1003

0.70

2.41

3.7

2.7

13.41

13.14

1.14

991

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

160

1253

1.28

2.41

1.5

0.35

0.37

nmol/l

0.17

128

955

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1323

0.74

2.37

1.4

1.5

55.57

59.60

ug/l

0.57

1323

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

508

1.44

2.35

1.1

0.12

11.33

nmol/l

—

105

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.75

2.27

1.5

1.6

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.33

2.21

1.2

1.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1852

17424

1.08

2.20

1.6

1.5

2.34

2.38

g/l

0.34

1136

10719

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

100

2.00

2.20

1.1

1.0

0.01

0.56

u/ml

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

583

1.39

2.19

3.3

3.5

136.95

182.27

nmol/l

0.34

578

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

131

1676

0.78

2.17

1.5

1.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

724

8008

0.90

2.17

2.3

12.57

13.05

nmol/l

0.78

646

7239

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

388

0.54

2.16

1.7

1.9

8.29

2.88

u/ml

—

121

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

222

1831

1.22

2.16

1.4

1.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

526

0.61

2.15

1.1

1.61

2.02

u/ml

—

177

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

303

2573

1.18

2.15

1.4

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

713

1.35

2.15

1.2

1.3

207.50

202.54

titre

0.02

130

(3012516) Albumin [Mass/volume] in Urine

2542

26647

0.94

2.13

3.5

3.6

56.58

51.20

mg/l

0.60

1735

17439

(3026389) Candida sp identified in Specimen by Organism specific culture

148

1169

1.27

2.13

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2591

27134

0.94

2.11

4.1

4.3

11.70

9.11

mg/mmol

1.51

1699

17340

(1002224) Polysomnography panel

331

3846

0.86

2.10

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

182

1.70

2.10

2.8

2.6

352.23

232.30

ug/l

0.12

182

(46235355) HIV 1 and 2 tests - Meaningful Use set

1707

16047

1.08

2.07

1.9

2.0

—

(3034426) Prothrombin time (PT)

276

1.56

2.07

1.3

1.2

31.91

28.45

1.62

276

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

277

2344

1.19

2.06

2.0

2.3

0.00

g/l

-0.00

250

2202

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

306

2614

1.18

2.04

2.0

2.2

0.04

0.03

g/l

0.07

269

2358

(3020874) Milk IgE Ab [Units/volume] in Serum

602

0.65

2.02

1.1

1.2

0.72

2.95

u/ml

2.17

252

(3033099) Centromere Ab [Titer] in Serum

177

1.70

2.01

1.3

1.1

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

240

2011

1.20

2.00

2.1

1.9

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

568

1.38

2.00

1.1

—

0.62

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

662

1.35

2.00

1.2

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

327

1.50

1.99

1.1

94.66

93.82

0.06

255

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

647

1.35

1.96

1.7

1.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

135

1695

0.79

1.95

1.1

2.90

2.20

u/ml

0.21

957

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

171

1391

1.23

1.93

1.2

1.1

7895.64

7435.45

iu/ml

0.02

322

(3026657) Rickettsia conorii Ab [Titer] in Serum

3.75

1.93

1.0

1.1

—

371.20

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

103

1334

0.77

1.92

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

180

1.67

1.90

1.1

—

21.56

u/ml

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

409

0.59

1.90

1.3

1.5

27.63

36.91

nmol/l

0.86

364

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

267

1.54

1.88

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.18

1.87

1.1

1.2

—

(3045788) Cell count panel - Pleural fluid

114

889

1.29

1.86

1.5

—

(3016135) IgD [Mass/volume] in Serum

3.53

1.83

1.0

1.2

24.57

33.22

mg/l

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

222

0.45

1.81

1.3

1.1

17.69

61.18

u/ml

—

215

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4122

39979

1.05

1.80

3.4

3.2

140.79

125.68

ug/l

2.11

3820

37394

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2070

19688

1.07

1.79

1.4

1.77

1.93

u/ml

0.19

555

5223

(3008116) Ketones [Moles/volume] in Urine by Test strip

199

1.61

1.79

1.7

1.4

0.26

0.37

mmol/l

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

1.95

1.79

4.2

3.7

9.43

3.62

—

(3012441) Differential panel - Pleural fluid

121

957

1.27

1.78

1.4

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

247

1.54

1.77

1.1

—

4.00

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.09

1.75

1.4

0.16

0.59

iu/ml

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

923

8526

1.09

1.75

4.2

4.3

11.84

30.51

ug/l

2.57

751

6967

(3044927) Protein electrophoresis panel - Urine

105

818

1.29

1.74

1.4

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.33

1.74

1.3

1.4

1.57

2.25

g/l

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

592

0.67

1.73

1.2

1.41

9.05

u/ml

0.97

210

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.22

1.73

1.1

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

170

1.65

1.72

1.1

1.2

—

(3017400) Magnesium [Moles/volume] in Urine

2.92

1.72

1.0

2.63

3.12

mmol/l

—

(3037522) Nuclear Ab [Titer] in Serum

1250

11701

1.08

1.72

1.4

464.31

513.87

titre

0.57

255

2420

(3010838) Calcium [Moles/time] in 24 hour Urine

171

1412

1.21

1.71

1.7

1.9

4.73

4.85

mmol/24h

0.22

154

1251

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

983

0.75

1.70

1.2

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

283

1.49

1.68

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

174

1443

1.21

1.67

1.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

639

1.32

1.67

2.2

2.0

1.98

1.40

u/field

0.50

347

(3002256) Pathology report gross observation

1021

10956

0.92

1.65

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

183

1528

1.20

1.65

1.8

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

503

5578

0.90

1.64

1.2

—

(40761536) Microorganisms panel - Urine sediment

726

6659

1.10

1.63

4.8

4.0

—

(3032057) Clostridioides difficile [Presence] in Stool

166

1.63

1.60

1.4

1.9

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.82

1.56

1.8

1.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

114

1414

0.80

1.55

1.1

2.86

4.20

u/ml

0.55

751

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

289

1.45

1.54

1.2

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.42

1.53

1.0

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

120

968

1.24

1.53

2.7

2.5

29.72

25.94

iu/ml

0.18

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1045

0.77

1.53

1.3

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.97

1.53

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

634

0.71

1.53

1.1

14.15

18.39

u/ml

0.29

238

(4024509) Urine culture

426

3815

1.12

1.52

2.2

2.0

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

3.33

1.52

1.0

183.20

157.87

g/l

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

233

1.50

1.51

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

436

3915

1.12

1.49

1.5

27.43

24.92

iu/l

0.77

351

3233

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

258

1.47

1.49

1.2

1.3

29.84

261.54

ug/l

1.32

124

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

1.95

1.48

2.1

1.8

4.34

1.35

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.95

1.48

2.1

1.8

0.64

0.91

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

1.95

1.48

2.1

1.8

0.93

0.85

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

1.95

1.48

2.1

1.8

1.44

1.68

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.95

1.48

2.1

1.8

2.65

1.32

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.95

1.48

2.1

1.8

6.98

3.24

mg/l

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

335

2967

1.13

1.45

6.0

5.8

1.51

1.49

mg/l

0.17

302

2734

(1617658) Protocol used for examination of sentinel lymph nodes

510

0.68

1.45

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1047

0.78

1.45

1.3

6.98

7.24

mmol/l

0.31

928

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

179

1.57

1.45

1.3

1.17

mmol/l

0.10

179

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

726

1.27

1.44

4.6

5.3

214.40

87.85

u/ml

0.50

234

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.73

1.43

1.0

1.3

—

mmol/l

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

464

1.34

1.42

1.4

1.8

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

464

1.34

1.42

1.4

1.8

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

289

0.59

1.40

1.0

1.2

11.15

15.77

u/ml

—

186

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1418

13440

1.06

1.38

1.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

175

2056

0.85

1.38

1.2

1.1

2.53

2.43

u/ml

0.04

1180

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

258

2255

1.15

1.38

1.9

2.0

12.10

11.88

mg/l

0.16

236

2112

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

471

4270

1.11

1.38

2.4

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.94

1.38

2.2

2.7

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.20

1.36

1.8

1.4

383.78

509.43

nmol/l

—

(3022621) pH of Urine by Test strip

716

6624

1.09

1.36

3.3

2.7

6.24

6.07

3.94

503

4482

(37021550) Renin [Units/volume] in Plasma --upright

174

1.55

1.36

1.3

150.90

110.63

mu/l

0.23

133

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

197

2289

0.86

1.36

1.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

494

1.32

1.36

1.4

1.5

6.36

9.36

ug/l

0.95

444

(3020961) Endomysium IgA Ab [Titer] in Serum

464

4207

1.11

1.36

1.2

1.1

230.45

152.91

titre

0.29

129

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.94

1.36

1.0

1.4

1.48

2.13

mu/l

—

(3020491) Glucose [Moles/volume] in Blood

609

1.28

1.34

1.8

2.0

7.74

6.57

mmol/l

1.79

439

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

469

1.32

1.34

1.2

1.08

1.06

ratio

0.60

375

(40768806) Pleura Pathology biopsy report

115

940

1.23

1.34

1.4

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1041

11064

0.93

1.34

1.4

1.5

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.87

1.34

2.1

1.8

1.18

1.04

mg/l

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

290

1.42

1.33

1.3

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

295

2609

1.13

1.33

1.4

264.14

274.58

ug/g

0.38

176

1540

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.14

1.33

1.2

1.5

18.83

30.03

nmol/l

—

(36660697) Celiac disease serology panel - Serum

757

7028

1.08

1.33

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2455

23656

1.05

1.33

4.2

3.4

0.13

0.23

estimate

0.36

833

7257

(3036071) Salmonella sp Ab [Titer] in Serum

266

1.43

1.31

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1219

0.81

1.30

1.0

1.1

0.18

0.49

u/ml

0.91

454

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

598

5502

1.09

1.30

1.2

90.31

137.32

u/ml

3.12

218

2008

(3042631) Mycobacterium sp identified in Specimen

134

1116

1.20

1.30

2.5

2.9

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

510

4658

1.10

1.30

2.0

2.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

133

1590

0.83

1.30

1.2

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.50

1.30

1.8

2.1

172.85

290.08

ug/l

—

(40768446) Kidney Pathology biopsy report

368

1.36

1.30

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

607

5593

1.09

1.28

2.1

2.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

499

1.30

1.28

1.5

1.4

4.86

4.78

umol/l

0.07

441

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

127

1518

0.83

1.25

1.9

1.8

—

(3042951) Complement C1q Ab [Units/volume] in Serum

2.22

1.24

1.0

1.1

—

26.59

—

(3003740) Influenza virus B Ag [Presence] in Specimen

134

1590

0.84

1.22

1.2

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

530

1.28

1.21

1.8

1.6

74.01

83.38

umol/l

2.67

530

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.16

1.21

1.0

1.2

224.50

297.50

nmol/l

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

229

1.44

1.21

1.3

1.6

12.37

13.29

g/l

0.20

174

(3010375) cycloSPORINE [Mass/volume] in Blood

426

1.32

1.19

27.7

28.4

108.24

116.43

ug/l

0.48

349

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

383

1.33

1.19

1.3

1.2

—

(3019174) dRVVT (LA screen)

1.83

1.19

1.1

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

428

3898

1.10

1.18

1.3

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

106

873

1.22

1.18

1.2

66.76

70.83

u/l

0.16

761

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

102

837

1.22

1.18

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

666

1.25

1.18

1.1

282.80

285.21

mg/l

0.09

607

(3008401) Mugwort IgE Ab [Units/volume] in Serum

149

1745

0.85

1.18

1.1

0.75

1.12

u/ml

0.57

870

(3016650) Hepatitis A virus Ab [Presence] in Serum

171

1471

1.16

1.17

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

117

1.62

1.17

1.6

2.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

154

1794

0.86

1.15

1.1

3.45

5.99

u/ml

2.20

1035

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

395

1.32

1.13

1.3

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

201

2292

0.87

1.12

2.0

1.9

194.84

206.37

pmol/l

0.83

185

2178

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

113

0.44

1.12

1.0

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

327

1.35

1.11

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

1107

0.82

1.11

2.2

2.7

5.11

8.67

umol/l

2.61

823

(3027456) Digoxin [Moles/volume] in Serum or Plasma

195

1704

1.15

1.10

3.5

3.2

0.73

0.82

nmol/l

3.31

154

1360

(40768793) Breast Pathology biopsy report

146

1701

0.86

1.10

1.3

—

(3012989) Citrate [Moles/time] in 24 hour Urine

2.38

1.09

2.4

1.4

1.34

2.16

mmol/24h

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.38

1.09

1.0

1.2

36.48

35.23

umol/24h

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.82

1.08

1.2

2.28

1.60

umol/24h

0.63

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

650

0.77

1.08

1.2

1.3

197.59

184.27

pmol/l

0.13

650

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8409

83459

1.06

1.08

16.8

12.1

26.24

26.58

u/l

0.68

8249

81069

(3004451) EKG impression Narrative

487

1.27

1.07

1.3

—

(3034891) Synovial lining cells/cells in Synovial fluid

374

0.69

1.07

1.5

5.11

3.84

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

666

1.23

1.07

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

222

1963

1.13

1.06

5.2

4.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

479

1.27

1.06

1.7

1.5

1.17

1.22

nmol/l

0.18

353

(3020393) Adenovirus Ag [Presence] in Stool

161

1.49

1.06

1.9

1.6

—

(3001186) Copper [Moles/volume] in Serum or Plasma

237

1.39

1.04

1.1

1.3

16.20

16.44

umol/l

0.10

208

(21494434) Karyotype in Bone marrow

751

1.21

1.03

1.3

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

171

1492

1.15

1.01

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

271

3009

0.90

1.01

1.8

1.9

46.66

40.57

nmol/l

2.37

265

2930

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

247

1.38

1.01

1.2

1.3

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.17

0.98

1.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

309

1.33

0.97

1.9

2.1

589.56

3287.34

e6/l

0.53

208

(3044009) aPTT.lupus sensitive (LA screen)

1.74

0.96

1.1

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

996

9461

1.06

0.96

4.7

4.9

32.53

32.36

0.16

704

6381

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

279

3082

0.90

0.96

1.6

22.25

15.85

u/ml

0.54

749

(3021879) Hepatitis B virus core Ab [Presence] in Serum

719

6762

1.07

0.95

1.5

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

157

1.47

0.95

1.3

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

157

1.47

0.95

1.3

1.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.95

0.0

1.0

—

6.17

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

146

1267

1.15

0.95

2.3

2.1

2.40

10.14

titre

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

174

1.44

0.94

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

114

1332

0.85

0.93

1.1

5.80

5.85

u/ml

0.01

642

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

117

1.54

0.93

1.2

1.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

171

1506

1.14

0.91

1.5

1.6

0.68

0.79

g/l

0.88

132

1181

(40761539) Cells [Type] in Urine sediment by Light microscopy

193

1.40

0.89

1.3

1.2

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.07

0.89

1.2

1.00

1.29

u/field

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

641

0.79

0.89

1.3

1.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

8476

84217

1.05

0.89

31.9

21.1

74.92

78.82

umol/l

17.98

8382

83190

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

663

6238

1.07

0.88

1.5

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

692

1.20

0.88

6.1

4.0

52.00

55.12

u/ml

0.05

683

(3026493) Urate [Moles/volume] in Serum or Plasma

2148

22128

0.96

0.88

3.0

2.8

328.11

347.11

umol/l

12.81

1861

19585

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

277

0.69

0.88

1.0

16.14

10.63

u/ml

0.32

184

(40765089) Chromosome analysis panel - Blood by G-banded

324

1.30

0.87

1.1

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

118

1016

1.16

0.87

1.4

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

109

933

1.17

0.86

1.3

0.39

0.40

g/l

0.07

675

(3027135) IgG subclass 1 [Mass/volume] in Serum

109

934

1.17

0.86

1.3

6.41

6.68

g/l

0.30

676

(3028192) IgG subclass 2 [Mass/volume] in Serum

109

934

1.17

0.86

1.3

2.72

2.90

g/l

0.36

679

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

413

0.75

0.85

2.1

2.0

149.14

174.10

ug/min

—

100

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.56

0.84

2.3

4.5

—

(3035880) pH of Pleural fluid

478

1.24

0.84

1.2

1.3

7.44

7.41

0.62

317

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

196

1.38

0.83

1.5

1.6

0.32

0.38

ug/l

0.48

129

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.75

0.83

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

434

0.76

0.83

8.5

5.9

1645.33

9321.75

u/ml

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

933

9778

0.95

0.82

2.2

—

(3025941) Bacteria identified in Stool by Culture

484

4520

1.07

0.82

1.2

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.69

0.82

1.0

2.7

—

82.19

—

(4062490) Immunoglobulin typing, IgG

107

920

1.16

0.82

1.4

1.3

—

(44806420) Estimation of glomerular filtration rate

851

0.83

0.81

2.4

—

(3045142) Bone marrow Pathology biopsy report

113

977

1.16

0.80

1.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.70

0.80

1.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

189

1.38

0.80

7.0

6.8

70.11

70.35

0.02

147

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5224

51493

1.03

0.80

3.2

3.1

—

(40762887) Creatinine [Moles/volume] in Blood

1.72

0.79

1.5

1.6

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

170

1516

1.12

0.78

1.1

8.39

18.02

au/ml

2.80

340

(4212803) Bone marrow aspirate examination

1.62

0.78

1.1

1.0

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.56

0.78

4.1

3.8

1.51

1.37

mg/l

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

511

1.21

0.77

1.2

149.73

91.02

u/l

1.47

428

(4281824) Cell count and differential, peritoneal fluid

791

0.83

0.76

1.3

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

157

1.40

0.76

1.4

1.2

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

226

1.33

0.75

1.3

58.00

55.96

0.11

187

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.52

0.75

1.4

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

650

1.19

0.75

2.1

1.6

32.72

24.73

u/ml

0.71

128

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.08

0.74

1.4

1.2

16.70

34.20

mg/24h

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

492

0.79

0.74

1.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

221

2008

1.10

0.73

1.3

1.4

23.08

54.76

u/ml

—

(3017704) Immunofixation for Urine

451

1.22

0.72

1.5

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.61

0.72

2.4

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.62

0.71

1.2

1.1

18.27

14.09

u/l

0.17

(3006571) Granulocytes/Leukocytes in Synovial fluid

946

0.85

0.71

1.7

1.6

56.44

59.28

0.30

603

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

498

1.21

0.71

1.2

31.87

25.74

u/l

0.27

409

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.58

0.71

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

110

1254

0.88

0.70

1.3

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

316

2930

1.08

0.68

2.1

1.8

—

32.21

—

(3049717) Cytology report of Urine Cyto stain

345

3210

1.08

0.68

2.3

2.8

—

(3009677) Dengue virus Ab [Presence] in Serum

1.85

0.68

1.2

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.56

0.68

1.0

1.1

0.04

0.03

u/ml

0.42

(40759836) Histone Ab [Presence] in Serum by Immunoblot

685

1.17

0.68

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

197

2163

0.91

0.67

1.1

4.98

7.89

eliau/ml

0.61

269

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

566

1.18

0.67

1.2

—

(40758358) Immune stain study

1.79

0.66

1.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

339

1.24

0.65

1.4

1.8

40.42

39.82

g/l

0.28

339

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.51

0.65

1.2

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

1.54

0.65

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

611

0.83

0.62

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

101

0.59

0.62

1.0

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

465

4392

1.06

0.61

1.1

1.08

9.15

u/ml

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

137

0.66

0.60

1.0

1.2

0.22

6.45

u/ml

—

114

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

950

0.87

0.59

1.6

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

132

1185

1.12

0.59

1.1

1.49

1.50

g/l

0.05

123

1077

(3000285) Sodium [Moles/volume] in Blood

166

1.33

0.58

1.3

1.2

132.69

138.92

mmol/l

2.53

133

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

455

1.19

0.58

1.2

1.1

24.47

25.70

u/l

0.07

402

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

558

1.17

0.56

1.2

—

(3001556) Androgen free Index in Serum or Plasma

0.57

0.56

1.2

1.3

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.57

0.56

1.0

1.2

—

41.58

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

189

1735

1.09

0.55

1.5

1.6

137.33

145.47

au/ml

0.35

529

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

194

1.29

0.55

1.4

1.1

20.07

20.17

mmol/l

0.03

173

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

266

1.24

0.55

1.5

1.9

13508.90

14781.69

e6/l

0.04

137

(3007463) Buprenorphine [Presence] in Urine

1.58

0.54

3.0

6.2

—

(3022670) pH of Venous cord blood

1.58

0.54

1.0

1.1

—

(3024263) Appearance of Synovial fluid

427

0.82

0.54

1.5

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

854

1.12

0.52

1.7

2.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

694

1.14

0.52

1.9

1.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

282

0.78

0.52

1.6

1.5

0.49

0.51

e9/l

0.13

282

(3036782) Glucose [Moles/volume] in Pleural fluid

883

1.12

0.52

1.3

1.4

6.21

6.37

mmol/l

0.29

818

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

204

1887

1.08

0.52

1.3

1.4

247.49

254.44

u/ml

0.16

129

1146

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

704

1.14

0.51

1.2

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

136

0.66

0.51

1.0

1.2

2.98

7.90

u/ml

—

116

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

225

0.75

0.50

1.1

1.3

4.55

9.37

u/ml

0.40

162

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

144

1.32

0.50

2.8

3.3

29.64

38.31

mg/l

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

213

0.75

0.50

1.0

1.1

22.88

40.37

iu/ml

1.15

213

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

237

2210

1.07

0.49

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

234

2181

1.07

0.49

1.8

2.0

2.99

6.37

iu/l

0.70

895

(3014051) Protein [Presence] in Urine by Test strip

2438

23924

1.03

0.49

3.4

3.0

0.09

0.06

0.26

566

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

6651

66954

0.98

0.49

30.8

20.1

13.66

13.62

1.60

6599

66062

(3009508) Creatinine [Moles/volume] in Urine

2871

29169

0.98

0.49

3.6

7.51

7.73

mmol/l

1.63

2462

24848

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.56

0.48

1.0

1.6

—

(40768797) Stomach Pathology biopsy report

1166

11326

1.03

0.48

1.2

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

432

0.83

0.48

5.1

4.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

678

0.87

0.48

1.1

10.01

9.09

iu/ml

0.09

167

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

206

1915

1.08

0.47

2.4

184.24

103.59

ug/min

1.55

116

1156

(3041918) Cholesterol [Moles/volume] in Pleural fluid

181

1.27

0.47

1.1

1.2

1.79

1.55

mmol/l

0.54

112

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

463

0.84

0.47

1.4

1.5

—

(3006270) Folate [Moles/volume] in Blood

672

1.13

0.47

1.1

1.2

313.36

357.67

nmol/l

1.26

559

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

137

1.31

0.47

1.4

1.6

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.47

0.46

1.0

1.1

112.00

96.47

titre

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

205

1908

1.08

0.46

1.5

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

583

5595

1.04

0.46

1.3

168.14

272.96

u/ml

3.14

542

5223

(3018333) Ribosomal P Ab [Presence] in Serum

636

1.13

0.45

1.2

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.61

0.45

1.4

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

816

1.12

0.45

3.4

3.8

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

153

0.72

0.45

1.1

2.0

1.85

1.99

ug/l

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.40

0.45

3.9

4.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

208

1942

1.07

0.44

1.4

1.3

2.77

3.63

u/ml

0.23

124

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.45

0.44

1.2

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

247

2321

1.07

0.43

1.4

1.3

4.04

5.10

u/ml

0.22

204

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

705

1.12

0.43

1.4

1.2

57.67

68.68

u/ml

—

(3047189) Immunofixation for 24 hour Urine

404

0.84

0.43

1.2

1.7

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

457

0.85

0.42

4.0

2.5

200.82

199.96

u/l

0.03

451

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

0.64

0.42

1.2

1.0

—

(3000012) Reticulocyte production index

139

1281

1.09

0.42

2.3

2.1

0.98

0.89

1.12

105

846

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.43

0.41

1.8

1.5

57.40

45.44

umol/l

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

295

1.19

0.41

1.4

1.2

0.31

0.30

g/l

0.30

240

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

661

1.12

0.41

1.2

—

(3024471) HLA-A [Type]

277

1.19

0.40

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

652

1.12

0.40

1.2

—

(40768443) Skin Pathology biopsy report

394

3763

1.05

0.40

1.2

—

(3020650) Glucose [Presence] in Urine

271

0.81

0.40

1.2

1.7

0.00

0.02

estimate

0.80

271

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.33

0.40

1.1

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1034

0.91

0.40

1.2

1.5

2.66

4.49

ug/l

2.87

928

(40761995) Spermatozoa Progressive [#/volume] in Semen

250

1.20

0.40

2.2

3.3

43.23

44.29

0.08

250

(3038026) Centromere Ab [Units/volume] in Serum

606

1.12

0.39

1.4

1.2

49.03

48.45

u/ml

—

(3025130) Human papilloma virus identified in Specimen

1054

0.91

0.39

1.6

1.8

—

(3016244) Insulin [Units/volume] in Serum or Plasma

625

1.12

0.39

2.3

3.3

21.67

24.29

mu/l

0.36

595

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

104

0.67

0.39

1.1

—

(4015189) Microbial culture of sputum

193

0.78

0.39

1.6

2.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

865

1.10

0.38

1.5

1.3

1.55

1.50

nmol/l

0.15

780

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

847

1.10

0.37

1.3

1.2

25.43

45.90

u/ml

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.35

0.37

1.2

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

724

0.90

0.36

3.1

3.0

80.76

59.26

mg/l

0.20

547

(3024932) HLA-DR beta [Type]

272

1.18

0.36

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

678

1.11

0.35

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.43

0.35

1.0

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

679

1.10

0.35

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

245

1.18

0.35

1.7

2.7

232.75

114.54

ng/l

0.44

167

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

775

1.10

0.34

1.2

1.4

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

163

1.23

0.34

1.8

2.1

6.08

7.92

mmol/l

2.54

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

372

0.86

0.34

1.2

8.25

9.66

mm/h

0.40

372

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

185

1743

1.06

0.33

2.3

2.0

0.93

0.83

nmol/l

1.04

149

1481

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

878

9001

0.97

0.33

2.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

768

1.09

0.33

1.5

1.4

155845.65

128505.28

e6/l

0.15

507

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

558

1.11

0.32

1.7

1.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.28

0.32

1.0

1.7

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

238

1.18

0.32

1.1

1.3

13.18

13.51

pmol/l

—

(3025577) Chromium [Mass/volume] in Blood

476

0.88

0.32

2.1

2.2

2.03

2.29

ug/l

0.29

396

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

321

3077

1.04

0.31

3.1

3.6

163.40

2376.18

u/ml

1.68

283

2644

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

244

2325

1.05

0.31

1.4

1.3

13.17

8.42

u/ml

0.43

325

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

1.32

0.30

1.4

1.2

16.57

1441.46

u/l

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

352

1.14

0.30

1.2

1.1

—

(3014891) Appearance of Pleural fluid

120

1.25

0.30

1.7

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

102

1.27

0.29

1.0

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

250

1.16

0.29

4.5

6.5

8.07

8.56

0.15

250

(3038071) Oxygen [Partial pressure] in Mixed venous blood

227

0.84

0.28

5.9

7.0

4.93

5.37

kpa

1.00

227

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

474

4593

1.03

0.28

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

162

0.80

0.28

2.2

1.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

418

0.88

0.28

1.2

1.3

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

151

0.79

0.28

1.3

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

498

1.10

0.27

1.5

1.6

6.31

6.52

u/l

0.05

398

(3048929) Epstein Barr virus Ab [Presence] in Serum

317

3055

1.04

0.26

1.3

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

500

1.10

0.26

1.8

1.5

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

717

0.92

0.25

1.4

1.5

34.87

29.54

0.62

438

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

329

1.12

0.25

1.0

1.1

1.42

8.47

u/ml

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

197

1.17

0.25

2.0

0.07

0.19

nmol/l

2.00

142

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

425

0.89

0.25

2.3

1.9

21.60

368.81

pmol/l

—

(37208534) Antinuclear antibody arbitrary concentration in serum

298

0.87

0.25

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

229

2386

0.96

0.25

1.5

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

783

1.07

0.24

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

667

1.08

0.24

3.1

2.6

27.33

29.84

mg/l

0.21

478

(3029396) Erythrocyte agglutination [Presence] in Blood

208

1.15

0.23

3.0

2.9

—

(44806071) Cardiolipin IgM antibody measurement

115

1.22

0.23

1.2

1.1

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.32

0.23

1.0

1.2

2.86

1.71

mg/l

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.28

0.23

1.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

435

4231

1.03

0.22

4.1

3.4

1.02

ratio

1.08

398

3812

(3032868) Hemoglobin electrophoresis panel in Blood

0.77

0.22

1.7

1.5

—

(3016750) Collection duration of Urine

439

1.09

0.21

2.4

2.3

498.58

493.57

min

0.12

324

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

627

0.92

0.21

1.3

2.42

3.57

u/ml

0.21

373

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.03

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.21

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

7.0

—

0.27

—

(40760512) CD34 cells/cells in Bone marrow

0.00

0.21

0.0

1.8

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

105

0.76

0.21

1.0

7.74

6.53

u/ml

—

105

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.0

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

6791

67652

1.01

0.20

33.3

20.8

334.02

332.56

g/l

30.85

6746

67233

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

10.53

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.20

0.0

1.1

—

70.64

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.2

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.20

0.0

1.1

—

38.69

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.20

0.0

6.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

116

1220

0.95

0.20

1.1

2.23

2.87

0.32

174

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

229

0.87

0.20

1.4

1.7

11.12

9.15

ug/l

0.61

229

(4146454) Self-monitoring of blood glucose

871

0.94

0.20

2.5

2.7

—

(3010937) Rubella virus Ab [Presence] in Serum

1.15

0.19

1.0

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.23

0.18

1.4

1.3

—

577.74

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

109

1.19

0.18

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

170

1765

0.96

0.18

3.2

3.6

231.69

813.76

u/ml

2.03

155

1614

(3005011) Chlamydia sp Ab [Titer] in Serum

128

1.17

0.18

1.5

—

(3006462) Nitrate [Presence] in Urine

367

1.09

0.18

2.3

3.5

—

(3042733) HLA Ab [Presence] in Serum

300

1.10

0.17

4.7

4.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.15

0.17

1.4

1.1

—

(3001729) Color of Synovial fluid

0.75

0.17

1.0

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

194

0.88

0.16

1.1

1.2

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.13

0.16

1.0

165.13

163.73

g/l

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

0.79

0.15

1.0

6.58

2.06

u/ml

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

185

1909

0.97

0.15

1.2

1.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.75

0.15

1.2

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

119

0.84

0.15

1.0

1.2

72.40

68.21

ug/l

—

119

(40768795) Lymph node Pathology biopsy report

830

0.95

0.15

1.1

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

140

1.14

0.15

1.3

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.79

0.14

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

481

0.93

0.14

1.0

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

254

2478

1.03

0.13

1.4

1.3

41.90

34.82

u/ml

0.19

123

(3048689) Calprotectin [Mass/mass] in Stool

1125

11129

1.01

0.13

2.3

2.6

158.77

133.71

ug/g

0.97

889

8923

(3034092) Cytoplasmic Ig cells/cells in Blood

100

0.80

0.13

17.5

8.6

0.20

0.19

—

100

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

346

0.92

0.13

1.0

1.1

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

7491

75019

0.99

0.12

23.4

16.0

86.09

81.34

ml/min/173m2

63.46

7013

69135

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

521

1.06

0.12

1.8

1.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

303

0.92

0.12

2.7

3.4

92.71

138.16

au/ml

—

(40765096) Chromosome analysis panel by Banding

272

0.92

0.12

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

463

1.06

0.12

7.3

7.1

17.69

103.10

ug/l

1.06

301

(4211845) Urine protein measurement

405

1.06

0.11

2.3

3.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

374

3676

1.02

0.11

3.3

3.7

134.75

65.15

u/ml

0.41

363

3548

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

250

0.92

0.11

2.1

1.8

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

105

1.14

0.11

1.0

1.1

0.57

0.74

u/ml

—

(44813793) Dust mix specific IgE antibody measurement

602

1.05

0.11

1.1

—

(3004775) Volume in Urine collected for unspecified duration

612

1.05

0.10

2.3

712.55

641.19

0.67

407

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

277

2820

0.98

0.10

1.5

74.06

6.18

iu/ml

0.62

532

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

515

1.05

0.10

1.3

1.6

10.92

6.15

u/l

0.58

447

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

702

1.04

0.10

1.3

1.4

82.17

78.27

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

106

1028

1.03

0.09

1.1

—

(3044007) Cell count panel - Peritoneal fluid

271

1.07

0.09

1.5

1.9

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.06

0.09

6.6

7.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

842

8344

1.01

0.09

1.7

1.8

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

155

1.10

0.09

6.3

7.6

9.99

10.45

0.33

155

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

705

0.96

0.09

1.2

106.24

106.75

pmol/l

0.02

705

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.07

0.08

2.3

3.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.77

0.08

1.6

1.8

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.08

0.08

4.4

5.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

716

1.03

0.08

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.04

0.08

4.0

5.7

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.04

0.08

1.4

2.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

302

3057

0.99

0.07

1.6

1.7

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.88

0.06

1.1

1.2

5.89

5.85

mmol/l

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

103

0.87

0.06

1.0

1.1

1.48

0.29

u/ml

—

103

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

203

0.94

0.06

1.5

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

208

2108

0.99

0.06

1.7

1.6

12590.76

14970.47

e6/l

0.52

143

1470

(3036670) Protein [Mass/volume] in Synovial fluid

253

0.95

0.05

1.4

1.2

41.11

39.55

g/l

0.22

130

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

333

0.96

0.05

3.1

4.6

9.88

8.78

mg/l

0.38

269

(40758292) HTLV I+II Ab panel - Serum

169

1.06

0.05

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

130

0.92

0.04

6.3

6.8

8.66

8.32

mmol/l

0.15

130

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

266

2635

1.01

0.04

1.4

1.3

186.79

221.43

miu/ml

0.80

100

1175

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

241

0.95

0.04

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

241

0.95

0.04

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

241

0.95

0.04

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

241

0.95

0.04

1.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

229

1.05

0.04

2.0

1.8

—

(3020876) Protein [Mass/time] in 24 hour Urine

111

1093

1.02

0.04

1.8

2.4

1.44

1.30

g/24h

0.24

647

(40768441) Liver Pathology biopsy report

643

0.98

0.03

1.6

1.5

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

112

1.07

0.02

1.0

1.1

0.07

4.33

u/ml

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

294

2922

1.01

0.02

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

510

1.02

0.02

2.2

2.0

103.20

110.87

ng/l

0.25

510

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

183

1842

0.99

0.02

1.4

1.2

61.34

40.53

u/ml

0.72

166

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

153

1.05

0.01

1.1

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

155

1559

0.99

0.01

1.4

1.3

55.33

33.84

u/l

0.71

138

1354

(3051387) C reactive protein [Mass/volume] in Capillary blood

172

1727

1.00

0.01

5.0

3.5

29.52

27.81

mg/l

0.23

121

1208

(3002619) Bacteria identified in Specimen by Culture

214

1.03

0.00

1.1

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

117

1165

1.00

0.00

1.3

1.2

4.24

15.33

u/ml

—

(3048879) Bone marrow aspiration report

211

0.99

0.00

2.1

1.9

—

2.00

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

156

1.03

0.00

1.5

96.26

119.69

ug/l

0.42

135

(3006598) pH of Arterial cord blood

155

1.03

0.00

1.0

—

(4133840) Spirometry

223

0.99

0.00

1.3

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

119

1.01

0.00

13.9

12.6

4.67

5.56

mmol/l

1.58

119

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

583

0.99

0.00

1.4

113.33

437.92

titre

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

105

0.95

0.00

1.3

1.6

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.91

0.00

1.2

1.1

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

-0.00

0.0

1.2

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

0.89

-0.00

1.0

23.70

12.54

u/ml

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.93

-0.00

1.4

1.5

264.00

322.30

umol/24h

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

15.67

—

(3017497) Pine Nut IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.03

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.90

-0.00

3.3

4.5

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3020399) Glucose [Mass/volume] in Urine

0.00

-0.00

0.0

2.2

—

0.07

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

5.3

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

1.82

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

59.00

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.00

-0.00

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

21.00

—

Mortality – FinRegistry

↥

Association

Association between endpoint FE_STRICT and mortality.

Females

Parameter	HR [95% CI]	p-value
FE_STRICT	3.574 [3.23, 3.96]	< 0.001
Birth year	0.993 [0.98, 1.0]	0.063

During the follow-up period (1.1.1998 — 31.12.2019), 9830 out of 29202 females with FE_STRICT died.

Males

Parameter	HR [95% CI]	p-value
FE_STRICT	3.485 [3.14, 3.87]	< 0.001
Birth year	0.983 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 12596 out of 33557 males with FE_STRICT died.

Mortality risk

Mortality risk for people of age

years, who have FE_STRICT.

N-year risk	Females	Males
1	0.289%	0.634%
5	1.789%	3.581%
10	4.845%	8.1%
15	9.14%	14.981%
20	15.75%	24.808%

Relationships between endpoints

↥

Index endpoint: FE_STRICT – Focal epilepsy, strict definition

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Focal epilepsy, strict definition

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints